Header

UZH-Logo

Maintenance Infos

Items where Subject is "04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology"

Navigate back| Up a level
Export as
Number of items at this level: 844.

Schwarz, Hila; Böni, Jürg; Kouyos, Roger D; Turk, Teja; Battegay, Edouard; Kohler, Malcolm; Müller, Rouven; Petry, Heidi; Sax, Hugo; Weber, Rainer; McGeer, Allison; Trkola, Alexandra; Kuster, Stefan P (2019). The TransFLUas influenza transmission study in acute healthcare - recruitment rates and protocol adherence in healthcare workers and inpatients. BMC Infectious Diseases, 19(1):446.

Kaserer, Alexander; Kiavialaitis, Greta Emilia; Braun, Julia; Schedler, Andreas; Stein, Philipp; Rössler, Julian; Spahn, Donat R; Studt, Jan-Dirk (2019). Impact of rivaroxaban plasma concentration on perioperative red blood cell loss. Transfusion:Epub ahead of print.

Lareida, Anna; Terziev, Robert; Grossenbacher, Bettina; Andratschke, Nicolaus; Roth, Patrick; Rohrmann, Sabine; Stahel, Rolf; Guckenberger, Matthias; Le Rhun, Emilie; Weller, Michael; Wolpert, Fabian (2019). Underweight and weight loss are predictors of poor outcome in patients with brain metastasis. Journal of Neuro-Oncology, 145(2):339-347.

Buhler, Stéphane; Baldomero, Helen; Ferrari-Lacraz, Sylvie; Nunes, José Manuel; Sanchez-Mazas, Alicia; Massouridi-Levrat, Stravroula; Heim, Dominik; Halter, Jörg; Nair, Gayathri; Chalandon, Yves; Schanz, Urs; Güngör, Tayfun; Nicoloso, Grazia; Tiercy, Jean-Marie; Passweg, Jakob; Villard, Jean (2019). High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation. Bone Marrow Transplantation, 54(10):1701-1709.

Stilgenbauer, Stephan; Aurran Schleinitz, Thérèse; Eichhorst, Barbara; Lang, Fabian; Offner, Fritz; Rossi, Jean-François; Schroyens, Wilfried; Van Den Neste, Eric; Ysebaert, Loïc; von Wangenheim, Ute; Ursula Kress, Uta; Blum, Petra; Zenz, Thorsten (2019). Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia. Leukemia, 33(10):2531-2535.

Bourgine, Paul E; Fritsch, Kristin; Pigeot, Sebastien; Takizawa, Hitoshi; Kunz, Leo; Kokkaliaris, Konstantinos D; Coutu, Daniel L; Manz, Markus G; Martin, Ivan; Schroeder, Timm (2019). Fate Distribution and Regulatory Role of Human Mesenchymal Stromal Cells in Engineered Hematopoietic Bone Organs. iScience, 19:504-513.

Muller, Yannick D; Vionnet, Julien; Beyeler, Franziska; Eigenmann, Philippe; Caubet, Jean-Christoph; Villard, Jean; Berney, Thierry; Scherer, Kathrin; Spertini, Francois; Peter Fricker, Michael; Lang, Claudia; Schmid-Grendelmeier, Peter; Benden, Christian; Roux Lombard, Pascale; Aubert, Vincent; Immer, Franz; Pascual, Manuel; Harr, Thomas; Swiss Transplant Cohort Study (2019). Management of allergy transfer upon solid organ transplantation. American Journal of Transplantation:online.

Chapiro, Elise; Pramil, Elodie; Diop, M'boyba; Roos-Weil, Damien; Dillard, Clémentine; Gabillaud, Clémentine; Maloum, Karim; Settegrana, Catherine; Baseggio, Lucile; Lesesve, Jean-François; Yon, Mélanie; Jondreville, Ludovic; Lesty, Claude; Davi, Frederic B; Le Garff-Tavernier, Magali; Droin, Nathalie M; Dessen, Philippe; Algrin, Caroline; Leblond, Veronique; Gabarre, Jean; Bouzy, Simon; Eclache, Virginie; Gaillard, Baptiste; Callet-Bauchu, Evelyne; Muller, Marc; Lefebvre, Christine; Nadal, Nathalie; Ittel, Antoine; Struski, Stephanie; Collonge-Rame, Marie-Agnès; et al (2019). Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving and MYC and TP53. Blood.

Hashwah, Hind; Bertram, Katrin; Stirm, Kristin; Stelling, Anna; Wu, Cheuk-Ting; Kasser, Sabrina; Manz, Markus G; Theocharides, Alexandre P; Tzankov, Alexandar; Müller, Anne (2019). The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma. EMBO Molecular Medicine, 12:e10576.

Schmid, Sabine; Klingbiel, Dirk; Aebi, Stefan; Goldhirsch, Aron; Mamot, Christoph; Munzone, Elisabetta; Nolè, Franco; Oehlschlegel, Christian; Pagani, Olivia; Pestalozzi, Bernhard; Rochlitz, Christoph; Thürlimann, Beat; von Moos, Roger; Weder, Patrik; Zaman, Khalil; Ruhstaller, Thomas (2019). Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data. BMC Cancer, 19:902.

Gotschy, Alexander; von Deuster, Constantin; van Gorkum, Robbert J H; Gastl, Mareike; Vintschger, Ella; Schwotzer, Rahel; Flammer, Andreas J; Manka, Robert; Stoeck, Christian T; Kozerke, Sebastian (2019). Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging. Journal of Cardiovascular Magnetic Resonance, 21:56.

Schwotzer, Rahel; Manz, Markus Gabriel; Pederiva, Stefanie; Waibel, Christine; Caspar, Clemens; Lerch, Erika; Flammer, Andreas; Brouwers, Sofie; Seeger, Harald; Heimgartner, Raphael; Fehr, Thomas; Rossi, Davide; Bianchi, Elena; Stussi, Georg; Ghilardi, Guido; Gerber, Bernhard (2019). Daratumumab for Relapsed or Refractory AL Amyloidosis with high Plasma Cell Burden. Hematological oncology:Epub ahead of print.

Lacour, Max; Hiltbrunner, Stefanie; Lee, Seok-Yun; Soltermann, Alex; Rushing, Elisabeth Jane; Soldini, Davide; Weder, Walter; Curioni-Fontecedro, Alessandra (2019). Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence. Clinical Lung Cancer, 20(5):391-396.

Hutmacher, Cornelia; Volta, Laura; Rinaldi, Francesco; Murer, Patrizia; Myburgh, Renier; Manz, Markus G; Neri, Dario (2019). Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia. Leukemia Research, 84:106178.

Lu, Junyan; Böttcher, Martin; Walther, Tatjana; Mougiakakos, Dimitrios; Zenz, Thorsten; Huber, Wolfgang (2019). Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity. Haematologica, 104(9):1830-1840.

Riesterer, Oliver; Frank Ciernik, I; Stahel, Rolf A; Xyrafas, Alexandros; Aebersold, Daniel M; Plasswilm, Ludwig; Mahmut Ozsahin, E; Zwahlen, Daniel R; Nackaerts, Kristiaan; Zimmermann, Frank; Sabrina Stark, L; Weder, Walter; Krayenbuehl, Jérôme; Swiss Group for Clinical Cancer Research (SAKK), ? (2019). Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial. Radiotherapy and Oncology, 138:121-125.

Nagler, Arnon; Labopin, Myriam; Dholaria, Bhagirathbhai; Finke, Jürgen; Brecht, Arne; Schanz, Urs; Niittyvuopio, Riitta; Neubauer, Andreas; Bornhäuser, Martin; Santarone, Stella; Beelen, Dietrich; Shimoni, Avichai; Rösler, Wolf; Giebel, Sebastian; Savani, Bipin N; Mohty, Mohamad (2019). Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. British Journal of Haematology, 186(5):767-776.

Jebaraj, Billy Michael Chelliah; Tausch, Eugen; Landau, Dan A; Bahlo, Jasmin; Robrecht, Sandra; Taylor-Weiner, Amaro N; Bloehdorn, Johannes; Scheffold, Annika; Mertens, Daniel; Böttcher, Sebastian; Kneba, Michael; Jäger, Ulrich; Zenz, Thorsten; Wenger, Michael K; Fingerle-Rowson, Guenter; Wendtner, Clemens; Fink, Anna-Maria; Wu, Catherine J; Eichhorst, Barbara; Fischer, Kirsten; Hallek, Michael; Döhner, Hartmut; Stilgenbauer, Stephan (2019). Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia. Leukemia, 33(9):2183-2194.

Giacopelli, Brian; Zhao, Qiuhong; Ruppert, Amy S; Agyeman, Akwasi; Weigel, Christoph; Wu, Yue-Zhong; Gerber, Madelyn M; Rabe, Kari G; Larson, Melissa C; Lu, Junyan; Blachly, James S; Rogers, Kerry A; Wierda, William G; Brown, Jennifer R; Rai, Kanti R; Keating, Michael; Rassenti, Laura Z; Kipps, Thomas J; Zenz, Thorsten; Shanafelt, Tait D; Kay, Neil E; Abruzzo, Lynne V; Coombes, Kevin R; Woyach, Jennifer A; Byrd, John C; Oakes, Christopher C (2019). Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia. Blood, 134(8):688-698.

van Seijen, Maartje; Brcic, Luka; Gonzales, Atilio Navarro; Sansano, Irene; Bendek, Matyas; Brcic, Iva; Lissenberg-Witte, Birgit; Korkmaz, H Ibrahim; Geiger, Thomas; Kammler, Rosita; Stahel, Rolf; Thunnissen, Erik; ETOP, ? (2019). Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen. Virchows Archiv, 475(2):191-199.

Gomariz, Alvaro; Isringhausen, Stephan; Helbling, Patrick M; Nombela-Arrieta, César (2019). Imaging and spatial analysis of hematopoietic stem cell niches. Annals of the New York Academy of Sciences:online.

Griggio, Valentina; Vitale, Candida; Todaro, Maria; Riganti, Chiara; Kopecka, Joanna; Salvetti, Chiara; Bomben, Riccardo; Dal Bo, Michele; Magliulo, Daniela; Rossi, Davide; Pozzato, Gabriele; Bonello, Lisa; Marchetti, Monia; Omedè, Paola; Kodipad, Ahad Ahmed; Laurenti, Luca; Del Poeta, Giovanni; Mauro, Francesca Romana; Bernardi, Rosa; Zenz, Thorsten; Gattei, Valter; Gaidano, Gianluca; Foà, Robin; Massaia, Massimo; Boccadoro, Mario; Coscia, Marta (2019). HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. Haematologica.

Ghilardi, Guido; Pabst, Thomas; Jeker, Barbara; Müller, Rouven; Cairoli, Anne; Müller, Antonia M S; Bargetzi, Mario; Hitz, Felicitas; Baldomero, Helen; Heim, Dominik; Schmidt, Adrian; Rossi, Davide; Ghielmini, Michele; Wannesson, Luciano; Lerch, Erika; Samaras, Panagiotis; Schanz, Urs; Passweg, Jakob R; Stussi, Georg; Kleber, Martina; Gerber, Bernhard (2019). Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study. Bone Marrow Transplantation, 54(7):1029-1037.

Lopez-Millan, Belen; Sanchéz-Martínez, Diego; Roca-Ho, Heleia; Gutiérrez-Agüera, Francisco; Molina, Oscar; Diaz de la Guardia, Rafael; Torres-Ruiz, Raúl; Fuster, Jose Luís; Ballerini, Paola; Suessbier, Ute; Nombela-Arrieta, Cesar; Bueno, Clara; Menéndez, Pablo (2019). NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia. Leukemia, 33(7):1557-1569.

Peters, S; Felip, E; Dafni, U; Belka, C; Guckenberger, M; Irigoyen, A; Nadal, E; Becker, A; Vees, H; Pless, M; Martinez-Marti, A; Tufman, A; Lambrecht, M; Andratschke, N; Piguet, A C; Kassapian, M; Roschitzki-Voser, H; Rabaglio-Poretti, M; Stahel, R A; Vansteenkiste, J; De Ruysscher, D (2019). Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial. Lung Cancer, 133:83-87.

Amon, Sabine; Meier-Abt, Fabienne; Gillet, Ludovic C; Dimitrieva, Slavica; Theocharides, Alexandre P A; Manz, Markus G; Aebersold, Ruedi (2019). Sensitive Quantitative Proteomics of Human Hematopoietic Stem and Progenitor Cells by Data-independent Acquisition Mass Spectrometry. Molecular & Cellular Proteomics, 18(7):1454-1467.

Schreiner, Philipp; Yilmaz, Bahtiyar; Rossel, Jean-Benoît; Franc, Yannick; Misselwitz, Benjamin; Scharl, Michael; Zeitz, Jonas; Frei, Pascal; Greuter, Thomas; Vavricka, Stephan R; Pittet, Valérie; Siebenhüner, Alexander; Juillerat, Pascal; von Känel, Roland; Macpherson, Andrew J; Rogler, Gerhard; Biedermann, Luc; Swiss IBD Cohort Study Group (2019). Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease. United European Gastroenterology Journal, 7(6):767-781.

Kresoja-Rakic, Jelena; Szpechcinski, Adam; Kirschner, Michaela B; Ronner, Manuel; Minatel, Brenda; Martinez, Victor D; Lam, Wan L; Weder, Walter; Stahel, Rolf; Früh, Martin; Cerciello, Ferdinando; Felley-Bosco, Emanuela (2019). miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery. Non-coding RNA, 5(2):E41.

Hüllein, Jennifer; Słabicki, Mikołaj; Rosolowski, Maciej; Jethwa, Alexander; Habringer, Stefan; Tomska, Katarzyna; Kurilov, Roma; Lu, Junyan; Scheinost, Sebastian; Wagener, Rabea; Huang, Zhiqin; Lukas, Marina; Yavorska, Olena; Helfrich, Hanne; Scholtysik, René; Bonneau, Kyle; Tedesco, Donato; Küppers, Ralf; Klapper, Wolfram; Pott, Christiane; Stilgenbauer, Stephan; Burkhardt, Birgit; Löffler, Markus; Trümper, Lorenz H; Hummel, Michael; Brors, Benedikt; Zapatka, Marc; Siebert, Reiner; Kreuz, Markus; Keller, Ulrich; et al (2019). MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma. Cancer Research, 79(12):3125-3138.

Dziadziuszko, Rafal; Smit, Egbert F; Dafni, Urania; Wolf, Juergen; Wasąg, Bartosz; Biernat, Wojciech; Finn, Stephen P; Kammler, Roswitha; Tsourti, Zoi; Rabaglio, Manuela; Ruepp, Barbara; Roschitzki-Voser, Heidi; Stahel, Rolf A; Felip, Enriqueta; Peters, Solange (2019). Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP). Journal of Thoracic Oncology, 14(6):1086-1094.

Frischknecht, Lukas; Britschgi, Christian; Galliker, Patricia; Christinat, Yann; Vichalkovski, Anton; Gstaiger, Matthias; Kovacs, Werner J; Krek, Wilhelm (2019). BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly. Scientific Reports, 9:7779.

Manz, Markus G; Russkamp, Norman F (2019). Selective CD117 HSC exchange therapy. Blood, 133(19):2007-2009.

Agarwal, Puneet; Isringhausen, Stephan; Li, Hui; Paterson, Andrew J; He, Jianbo; Gomariz, Álvaro; Nagasawa, Takashi; Nombela-Arrieta, César; Bhatia, Ravi (2019). Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells. Cell Stem Cell, 24(5):769-784.e6.

Zeijlemaker, Wendelien; Grob, Tim; Meijer, Rosa; Hanekamp, Diana; Kelder, Angèle; Carbaat-Ham, Jannemieke C; Oussoren-Brockhoff, Yvonne J M; Snel, Alexander N; Veldhuizen, Dennis; Scholten, Willemijn J; Maertens, Johan; Breems, Dimitri A; Pabst, Thomas; Manz, Markus G; van der Velden, Vincent H J; Slomp, Jennichjen; Preijers, Frank; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Löwenberg, Bob; Valk, Peter J M; Jongen-Lavrencic, Mojca; Ossenkoppele, Gert J; Schuurhuis, Gerrit J (2019). $CD34^+CD38^-$ leukemic stem cell frequency to predict outcome in acute myeloid leukemia. Leukemia, 33(5):1102-1112.

Gerull, S; Tschan-Plessl, A; Mathew, R; Nair, G; Passweg, J R; Halter, J P (2019). Late relapse after stopping sorafenib in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplantation, 54(5):769-771.

Kerr, Keith M; Thunnissen, Erik; Dafni, Urania; Finn, Stephen P; Bubendorf, Lukas; Soltermann, Alex; Verbeken, Eric; Biernat, Wojciech; Warth, Arne; Marchetti, Antonio; Speel, Ernst-Jan M; Pokharel, Sarawati; Quinn, Anne Marie; Monkhorst, Kim; Navarro, Atilio; Madsen, Line Bille; Radonic, Teodora; Wilson, Joan; De Luca, Graziano; Gray, Steven G; Cheney, Richard; Savic, Spasenija; Martorell, Miguel; Muley, Thomas; Baas, Paul; Meldgaard, Peter; Blackhall, Fiona; Dingemans, Anne-Marie; Dziadziuszko, Rafal; Vansteenkiste, Johan; Weder, Walter; Stahel, Rrolf; et al (2019). A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project. Lung Cancer, 131:95-103.

Curioni-Fontecedro, Alessandra; Perentes, Jean Yannis; Gelpke, Hans; Xyrafas, Alexandros; Bouchaab, Hasna; Mach, Nicolas; Matzinger, Oscar; Stojcheva, Nina; Frueh, Martin; Weder, Walter; Cathomas, Richard; Gargiulo, Piera; Bubendorf, Lukas; Pless, Miklos; Betticher, Daniel; Peters, Solange (2019). Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08). British Journal of Cancer, 120(10):968-974.

Fabris, Luca; Perugorria, María J; Mertens, Joachim; Björkström, Niklas K; Cramer, Thorsten; Lleo, Ana; Solinas, Antonio; Sänger, Hanna; Lukacs-Kornek, Veronika; Moncsek, Anja; Siebenhüner, Alexander; Strazzabosco, Mario (2019). The tumour microenvironment and immune milieu of cholangiocarcinoma. Liver International, 39 Suppl:63-78.

Fritsch, Kristin; Pigeot, Sébastien; Feng, Xiaomin; Bourgine, Paul E; Schroeder, Timm; Martin, Ivan; Manz, Markus G; Takizawa, Hitoshi (2019). Erratum to "Engineered humanized bone organs maintain human hematopoiesis in vivo": [Experimental Hematology 61 (2018) 45-51]. Experimental Hematology, 72:72.

Schmid, S; Klingbiel, D; Aeppli, S; Britschgi, C; Gautschi, O; Pless, M; Rothschild, S; Wannesson, L; Janthur, W; Foerbs, D; Demmer, I; Jochum, W; Früh, M (2019). Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort study. Lung Cancer, 130:149-155.

Malehmir, Mohsen; Pfister, Dominik; Gallage, Suchira; Szydlowska, Marta; Inverso, Donato; Kotsiliti, Elena; Leone, Valentina; Peiseler, Moritz; Surewaard, Bas G J; Rath, Dominik; Ali, Adnan; Wolf, Monika Julia; Drescher, Hannah; Healy, Marc E; Dauch, Daniel; Kroy, Daniela; Krenkel, Oliver; Kohlhepp, Marlene; Engleitner, Thomas; Olkus, Alexander; Sijmonsma, Tjeerd; Volz, Julia; Deppermann, Carsten; Stegner, David; Helbling, Patrick; Nombela-Arrieta, César; Rafiei, Anahita; Hinterleitner, Martina; Rall, Marcel; Baku, Florian; Weber, Achim; et al (2019). Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. Nature Medicine, 25(4):641-655.

López, Cristina; Kleinheinz, Kortine; Aukema, Sietse M; Rohde, Marius; Bernhart, Stephan H; Hübschmann, Daniel; Wagener, Rabea; Toprak, Umut H; Raimondi, Francesco; Kreuz, Markus; Waszak, Sebastian M; Huang, Zhiqin; Sieverling, Lina; Paramasivam, Nagarajan; Seufert, Julian; Sungalee, Stephanie; Russell, Robert B; Bausinger, Julia; Kretzmer, Helene; Ammerpohl, Ole; Bergmann, Anke K; Binder, Hans; Borkhardt, Arndt; Brors, Benedikt; Claviez, Alexander; Doose, Gero; Feuerbach, Lars; Haake, Andrea; Hansmann, Martin-Leo; Hoell, Jessica; et al (2019). Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nature Communications, 10(1):1459.

Mürner, Céline M; Stenner-Liewen, Frank; Seifert, Burkhardt; Mueller, Nicolas J; Schmidt, Adrian; Renner, Christoph; Schanz, Urs; Knuth, Alexander; Manz, Markus G; Scharl, Michael; Gerber, Bernhard; Samaras, Panagiotis (2019). Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation. Leukemia & Lymphoma, 60(3):685-695.

Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Dürig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco; Hopfinger, Georg (2019). New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance. Leukemia & Lymphoma, 60(3):649-657.

Leeksma, Alexander C; Taylor, Justin; Wu, Bian; et al; Zenz, Thorsten (2019). Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia. Leukemia, 33(2):390-402.

Peters, Solange; Dafni, Urania; Boyer, Michael; De Ruysscher, Dirk; Faivre-Finn, Corinne; Felip, Enriqueta; Garrido, Pilar; Girard, Nicolas; Guckenberger, Matthias; Haanen, John; Le Pechoux, Cecile; Mornex, Francoise; Ozsahin, Mahmut; Paz-Ares, Luis; Planchard, David; Raben, David; Ramalingam, Suresh; Reck, Martin; Smit, Egbert; Stahel, Rolf; Stenzinger, Albrecht; Swanton, Charlie; Vallone, Stefania; Garassino, Marina (2019). Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III Non-Small Cell Lung Cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). Annals of Oncology, 30(2):161-165.

Gastl, Mareike; Peereboom, Sophie M; Gotschy, Alexander; Fuetterer, Maximilian; von Deuster, Constantin; Boenner, Florian; Kelm, Malte; Schwotzer, Rahel; Flammer, Andreas J; Manka, Robert; Kozerke, Sebastian (2019). Myocardial triglycerides in cardiac amyloidosis assessed by proton cardiovascular magnetic resonance spectroscopy. Journal of Cardiovascular Magnetic Resonance, 21(1):10.

Scully, Marie; Cataland, Spero R; Peyvandi, Flora; Coppo, Paul; Knöbl, Paul; Kremer Hovinga, Johanna A; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Callewaert, Filip; Biswas, Debjit; De Winter, Hilde; Zeldin, Robert K; HERCULES Investigators (2019). Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. New England Journal of Medicine, 380(4):335-346.

Song, Yuanbin; Rongvaux, Anthony; Taylor, Ashley; Jiang, Tingting; Tebaldi, Toma; Balasubramanian, Kunthavai; Bagale, Arun; Terzi, Yunus Kasim; Gbyli, Rana; Wang, Xiaman; Fu, Xiaoying; Gao, Yimeng; Zhao, Jun; Podoltsev, Nikolai; Xu, Mina; Neparidze, Natalia; Wong, Ellice; Torres, Richard; Bruscia, Emanuela M; Kluger, Yuval; Manz, Markus G; Flavell, Richard A; Halene, Stephanie (2019). A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies. Nature Communications, 10(1):366.

Peters, Solange; Stahel, Rolf; Bubendorf, Lukas; Bonomi, Philip; Villegas, Augusto; Kowalski, Dariusz M; Baik, Christina S; Isla, Dolores; Carpeno, Javier De Castro; Garrido, Pilar; Rittmeyer, Achim; Tiseo, Marcello; Meyenberg, Christoph; de Haas, Sanne; Lam, Lisa H; Lu, Michael W; Stinchcombe, Thomas E (2019). Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers. Clinical Cancer Research, 25(1):64-72.

Schreiber, Peter W; Bischoff-Ferrari, Heike A; Boggian, Katia; van Delden, Christian; Enriquez, Natalia; Fehr, Thomas; Garzoni, Christian; Hirsch, Hans H; Hirzel, Cédric; Manuel, Oriol; Meylan, Pascal; Saleh, Lanja; Weisser, Maja; Mueller, Nicolas J; Swiss Transplant Cohort Study (2019). Vitamin D status and risk of infections after liver transplantation in the Swiss Transplant Cohort Study. Transplant International, 32(1):49-58.

Früh, Martin; Betticher, Daniel C; Stupp, Roger; Xyrafas, Alexandros; Peters, Solange; Ris, Hans Beat; Mirimanoff, Rene Olivier; Ochsenbein, Adrian F; Schmid, Ralph; Matzinger, Oscar; Stahel, Rolf A; Weder, Walter; Guckenberger, Matthias; Rothschild, Sacha I; Lardinois, Didier; Mach, Nicholas; Mark, Michael; Gautschi, Oliver; Thierstein, Sandra; Biaggi Rudolf, Christine; Pless, Miklos (2019). Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01). Journal of Thoracic Oncology, 14(1):115-123.

Widmer, Corinne C (2019). Allogenic Stem Cell Transplantation and the Subsequent Paraproteinemia: A Benign Altered B-Cell Homeostasis? Acta Haematologica, 141(1):12-13.

Suessbier, Ute; Nombela-Arrieta, César (2019). Assessing Cellular Hypoxic Status In Situ Within the Bone Marrow Microenvironment. Methods in Molecular Biology, 2017:123-134.

Tomska, Katarzyna; Scheinost, Sebastian; Zenz, Thorsten (2019). Lymphoma and Leukemia Cell Vulnerabilities and Resistance Identified by Compound Library Screens. Methods in Molecular Biology, 1956:351-362.

Gannon, Hugh S; Zou, Tao; Kiessling, Michael K; Gao, Galen F; Cai, Diana; Choi, Peter S; Ivan, Alexandru P; Buchumenski, Ilana; Berger, Ashton C; Goldstein, Jonathan T; Cherniack, Andrew D; Vazquez, Francisca; Tsherniak, Aviad; Levanon, Erez Y; Hahn, William C; Meyerson, Matthew (2018). Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells. Nature Communications, 9(1):5450.

Theocharides, Alexandre P. The genetic dissection of myeloproliferative neoplasms. 2018, University of Zurich, Faculty of Medicine.

Kabrani, Eleni; Chu, Van Trung; Tasouri, Evangelia; Sommermann, Thomas; Baßler, Kevin; Ulas, Thomas; Zenz, Thorsten; Bullinger, Lars; Schultze, Joachim L; Rajewsky, Klaus; Sander, Sandrine (2018). Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells. Blood, 132(25):2670-2683.

Doerschner, Miriam; Pekar-Lukacs, Agnes; Messerli-Odermatt, Olivia; Dommann-Scherrer, Corina; Rütti, Markus; Müller, Antonia M; Nair, Gayathri; Kamarachev, Jivko; Kerl, Katrin; Beer, Marc; Messerli, Michael; Frauenknecht, Katrin; Haralambieva, Eugenia; Hoetzenecker, Wolfram; French, Lars E; Guenova, Emmanuella (2018). Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement. British Journal of Dermatology:Epub ahead of print.

Tallon de Lara, Paulino; Cecconi, Virginia; Hiltbrunner, Stefanie; Yagita, Hideo; Friess, Martina; Bode-Lesniewska, Beata; Opitz, Isabelle; Vrugt, Bart; Weder, Walter; Stolzmann, Paul; Felley-Bosco, Emanuela; Stahel, Rolf A; Tischler, Verena; Britschgi, Christian; Soldini, Davide; van den Broek, Maries; Curioni Fontecedro, Alessandra (2018). Gemcitabine synergizes with immune checkpoint inhibitors and overcomes resistance in a preclinical model and mesothelioma patients. Clinical Cancer Research, 24(24):6345-6354.

Rulle, Undine; Tsourti, Zoi; Casanova, Ruben; Deml, Karl-Friedrich; Verbeken, Eric; Thunnissen, Erik; Warth, Arne; Cheney, Richard; Sejda, Aleksandra; Speel, Ernst Jan; Madsen, Line Bille; Nonaka, Daisuke; Navarro, Atilio; Sansano, Irene; Marchetti, Antonio; Finn, Stephen P; Monkhorst, Kim; Kerr, Keith M; Haberecker, Martina; Wu, Chengguang; Zygoura, Panagiota; Kammler, Roswitha; Geiger, Thomas; Gendreau, Steven; Schulze, Katja; Vrugt, Bart; Wild, Peter; Moch, Holger; Weder, Walter; Ciftlik, Ata Tuna; Dafni, Urania; Peters, Solange; Bubendorf, Lukas; Stahel, Rolf; Soltermann, Alex (2018). Computer-based intensity measurement assists pathologists in scoring PTEN immunohistochemistry - Clinical associations in NSCLC patients of the ETOP Lungscape cohort. Journal of Thoracic Oncology, 13(12):1851-1863.

Elmiger, R; Schanz, U; Ott, B; Frei, D (2018). Exposure of a Service Technician Repairing a Biplane X-Ray System. Radiation Protection Dosimetry, 182(1):18-19.

Kuster, Sabine; Stampf, Susanne; Gerber, Bernhard; Baettig, Veronika; Weisser, Maja; Gerull, Sabine; Medinger, Michael; Passweg, Jakob; Schanz, Urs; Garzoni, Christian; Berger, Christoph; Chalandon, Yves; Mueller, Nicolas J; van Delden, Christian; Neofytos, Dionysios; Khanna, Nina; Swiss Transplant Cohort Study (2018). Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study. Transplant Infectious Disease, 20(6):e12981.

Peters, Solange; Curioni-Fontecedro, Alessandra; Nechushtan, Hovav; Shih, Jin-Yuan; Liao, Wei-Yu; Gautschi, Oliver; Spataro, Vito; Unk, Mojca; Chih-Hsin Yang, James; Lorence, Robert M; Carrière, Philippe; Cseh, Agnieszka; Chang, Gee-Chen (2018). Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation-Positive Advanced NSCLC: Findings From a Global Named Patient Use Program. Journal of Thoracic Oncology, 13(12):1897-1905.

Schwyzer, Moritz; Ferraro, Daniela A; Muehlematter, Urs J; Curioni-Fontecedro, Alessandra; Huellner, Martin W; von Schulthess, Gustav K; Kaufmann, Philipp A; Burger, Irene A; Messerli, Michael (2018). Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results. Lung Cancer, 126:170-173.

Blumenthal, Gideon M; Bunn, Paul A; Chaft, Jamie E; McCoach, Caroline E; Perez, Edith A; Scagliotti, Giorgio V; Carbone, David P; et al; Stahel, Rolf A (2018). Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer. Journal of Thoracic Oncology, 13(12):1818-1831.

Unseld, Matthias; Drimmel, Magdalena; Siebenhüner, Alexander; Gleiss, Andreas; Bianconi, Daniela; Kieler, Markus; Scheithauer, Werner; Winder, Thomas; Prager, Gerald W (2018). Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib. Clinical Colorectal Cancer, 17(4):274-279.

Tugues, Sonia; Amorim, Ana; Spath, Sabine; Martin-Blondel, Guillaume; Schreiner, Bettina; De Feo, Donatella; Lutz, Mirjam; Guscetti, Franco; Apostolova, Petya; Haftmann, Claudia; Hasselblatt, Peter; Núñez, Nicolas G; Hottiger, Michael O; van den Broek, Maries; Manz, Markus G; Zeiser, Robert; Becher, Burkhard (2018). Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF–licensed myeloid cells. Science Translational Medicine, 10(469):eaat8410.

Schneider, Marcel André; Eden, Janina; Pache, Basile; Laminger, Felix; Lopez-Lopez, Victor; Steffen, Thomas; Hübner, Martin; Kober, Friedrich; Roka, Sebastian; Campos, Pedro Cascales; Roth, Lilian; Gupta, Anurag; Siebenhüner, Alexander; Kepenekian, Vahan; Passot, Guillaume; Gertsch, Philippe; Glehen, Olivier; Lehmann, Kuno (2018). Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin. Annals of Surgery, 268(5):845-853.

Simonis, Alexander; Fux, Michaela; Nair, Gayathri; Mueller, Nicolas J; Haralambieva, Eugenia; Pabst, Thomas; Pachlopnik Schmid, Jana; Schmidt, Adrian; Schanz, Urs; Manz, Markus G; Müller, Antonia M S (2018). Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature. Annals of Hematology, 97(10):1961-1973.

Galimberti, Viviana; Cole, Bernard F; Viale, Giuseppe; Veronesi, Paolo; Vicini, Elisa; Intra, Mattia; et al; Varga, Zsuzsanna; Moch, Holger (2018). Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncology, 19(10):1385-1393.

Theocharides, Alexandre P A; Manz, Markus G (2018). Finally: development of humanized lymph nodes. Nature Methods, 15(8):580-582.

Hegemann, I; Ganter, C; Widmer, C C; Becker, M; Müller, D; Spahn, D R (2018). Ongoing redistribution of dabigatran necessitates repetitive application of idarucizumab. British Journal of Anaesthesia, 121(2):505-508.

De Luca, Roberto; Kachel, Paul; Kropivsek, Klara; Snijder, Berend; Manz, Markus G; Neri, Dario (2018). A novel dual-cytokine-antibody fusion protein for the treatment of CD38-positive malignancies. Protein Engineering, Design & Selection, 31(5):173-179.

Gomariz, Alvaro; Helbling, Patrick M; Isringhausen, Stephan; Suessbier, Ute; Becker, Anton; Boss, Andreas; Nagasawa, Takashi; Paul, Grégory; Goksel, Orcun; Székely, Gábor; Stoma, Szymon; Nørrelykke, Simon F; Manz, Markus G; Nombela-Arrieta, César (2018). Quantitative spatial analysis of haematopoiesis-regulating stromal cells in the bone marrow microenvironment by 3D microscopy. Nature Communications, 9(1):2532.

Argelaguet, Ricard; Velten, Britta; Arnol, Damien; Dietrich, Sascha; Zenz, Thorsten; Marioni, John C; Buettner, Florian; Huber, Wolfgang; Stegle, Oliver (2018). Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets. Molecular Systems Biology, 14(6):e8124.

Manz, Markus G (2018). Plasmacytoid dendritic cells: origin matters. Nature Immunology, 19(7):652-654.

Gillison, Maura L; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A Dimitrios; Licitra, Lisa; Harrington, Kevin J; Kasper, Stefan; Vokes, Everett E; Even, Caroline; Worden, Francis; Saba, Nabil F; Iglesias Docampo, Lara Carmen; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Monga, Manish; Lynch, Mark; Li, Li; Ferris, Robert L (2018). CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer. The Oncologist, 23(9):1079-1082.

Giebel, Sebastian; Labopin, Myriam; Potter, Michael; Poiré, Xavier; Sengeloev, Henrik; Socié, Gerard; Huynh, Anne; Afanasyev, Boris V; Schanz, Urs; Ringden, Olle; Kalhs, Peter; Beelen, Dietrich W; Campos, Antonio M; Masszi, Tamás; Canaani, Jonathan; Mohty, Mohamad; Nagler, Arnon (2018). Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT. European Journal of Cancer, 96:73-81.

Roider, E; Signer, C; Fehrenbacher, B; Metzler, G; Schaller, M; Kamarachev, J; Kerl, K; Balabanov, S; Jochum, W; Hoetzenecker, W; Cozzio, A; French, L; Dummer, R; Guenova, E (2018). Individualized treatment approaches for Langerhans cell histiocytosis. British Journal of Dermatology, 178(6):1423-1424.

Ferris, Robert L; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A Dimitrios; Licitra, Lisa; Harrington, Kevin J; Kasper, Stefan; Vokes, Everett E; Even, Caroline; Worden, Francis; Saba, Nabil F; Docampo, Lara Carmen Iglesias; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Lynch, Mark; Jayaprakash, Vijayvel; Li, Li; Gillison, Maura L (2018). Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral Oncology, 81:45-51.

Britschgi, Christian; Riesterer, Oliver; Burger, Irene A; Guckenberger, Matthias; Curioni-Fontecedro, Alessandra (2018). Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer. Radiation Oncology, 13(1):102.

Schneider, Paul M; Eshmuminov, Dilmurodjon; Rordorf, Tamara; Vetter, Diana; Veit-Haibach, Patrick; Weber, Achim; Bauerfeind, Peter; Samaras, Panagiotis; Lehmann, Kuno (2018). 18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study. BMC Cancer, 18:548.

Fritsch, Kristin; Pigeot, Sébastien; Feng, Xiaomin; Bourgine, Paul E; Schroeder, Timm; Martin, Ivan; Manz, Markus G; Takizawa, Hitoshi (2018). Engineered humanized bone organs maintain human hematopoiesis in vivo. Experimental Hematology, 61:45-51.e5.

Brüggen, Marie-Charlotte; Kerl, Katrin; Haralambieva, Eugenia; Schanz, Urs; Chang, Yun-Tsan; Ignatova, Desislava; Dummer, Reinhard; Cozzio, Antonio; Hoetzenecker, Wolfram; French, Lars E; Guenova, Emmanuella (2018). Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study. Acta Dermato-Venereologica, 98(9):835-841.

Jethwa, Alexander; Słabicki, Mikołaj; Hüllein, Jennifer; Jentzsch, Marius; Dalal, Vineet; Rabe, Sophie; Wagner, Lena; Walther, Tatjana; Klapper, Wolfram; Bohnenberger, Hanibal; Rettel, Mandy; Lu, Junyan; Smits, Arne H; Stein, Frank; Savitski, Mikhail M; Huber, Wolfgang; Aylon, Yael; Oren, Moshe; Zenz, Thorsten (2018). TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma. Blood, 131(25):2789-2802.

McClain, Kenneth L; Picarsic, Jennifer; Chakraborty, Rikhia; et al; Manz, M G (2018). CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions. Cancer, 124(12):2607-2620.

Finazzi, T; Rordorf, T; Ikenberg, K; Huber, G F; Guckenberger, M; Garcia Schueler, H I (2018). Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy. BMC Cancer, 18(1):395.

Lickert, Sebastian; Sorrentino, Simona; Studt, Jan-Dirk; Medalia, Ohad; Vogel, Viola; Schoen, Ingmar (2018). Morphometric analysis of spread platelets identifies integrin αβ-specific contractile phenotype. Scientific Reports, 8(1):5428.

Kaserer, Alexander; Schedler, Andreas; Jetter, Alexander; Seifert, Burkhardt; Spahn, Donat R; Stein, Philipp; Studt, Jan-Dirk (2018). Risk Factors for Higher-than-Expected Residual Rivaroxaban Plasma Concentrations in Real-Life Patients. Thrombosis and Haemostasis, 118(05):808-817.

Stelling, Anna; Hashwah, Hind; Bertram, Katrin; Manz, Markus G; Tzankov, Alexandar; Müller, Anne (2018). The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma. Blood, 131(20):2235-2246.

Rothenbühler, Christoph; Held, Ulrike; Manz, Markus G; Schanz, Urs; Gerber, Bernhard (2018). Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia. Hematological oncology, 36(2):471-480.

Dürr, Claudia; Hanna, Bola S; Schulz, Angela; Lucas, Fabienne; Zucknick, Manuela; Benner, Axel; Clear, Andrew; Ohl, Sibylle; Öztürk, Selcen; Zenz, Thorsten; Stilgenbauer, Stephan; Li-Weber, Min; Krammer, Peter H; Gribben, John G; Lichter, Peter; Seiffert, Martina (2018). Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin. Haematologica, 103(4):688-697.

Jongen-Lavrencic, Mojca; Grob, Tim; Hanekamp, Diana; Kavelaars, François G; Al Hinai, Adil; Zeilemaker, Annelieke; Erpelinck-Verschueren, Claudia A J; Gradowska, Patrycja L; Meijer, Rosa; Cloos, Jacqueline; Biemond, Bart J; Graux, Carlos; van Marwijk Kooy, Marinus; Manz, Markus G; Pabst, Thomas; Passweg, Jakob R; Havelange, Violaine; Ossenkoppele, Gert J; Sanders, Mathijs A; Schuurhuis, Gerrit J; Löwenberg, Bob; Valk, Peter J M (2018). Molecular Minimal Residual Disease in Acute Myeloid Leukemia. New England Journal of Medicine, 378(13):1189-1199.

Andersson, E I; Pützer, S; et al; Mustjoki, S (2018). Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling. Leukemia, 32(3):774-787.

Hodel, Lucas; Inci, Ilhan; Schanz, Urs; Vrugt, Bart; Weder, Walter; Hillinger, Sven (2018). Urokinase application for hemothorax in pulmonary mucormycosis. Journal of Thoracic Disease, 10(3):E175-E178.

Malcikova, J; Tausch, E; Rossi, D; Sutton, L A; Soussi, T; Zenz, T; Kater, A P; Niemann, C U; Gonzalez, D; Davi, F; Gonzalez Diaz, M; Moreno, C; Gaidano, G; Stamatopoulos, K; Rosenquist, R; Stilgenbauer, S; Ghia, P; Pospisilova, S (2018). ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation. Leukemia, 32(5):1070-1080.

Fischer, Angela; Bastian, Sara; Cogliatti, Sergio; Mey, Ulrich; Saub, Jenny; Schanz, Urs; Padberg, Barbara; Hohloch, Karin (2018). Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome. Hematological oncology, 36(1):370-371.

Schnegg-Kaufmann, A; Feller, A; Baldomero, H; Rovo, A; Manz, M G; Gregor, M; Efthymiou, A; Bargetzi, M; Hess, U; Spertini, O; Chalandon, Y; Passweg, J R; Stussi, G; Arndt, V; Bonadies, N; NICER Working Group; Rohrmann, Sabine (2018). Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013. Cancer Epidemiology, 52:55-62.

Widmer, F; Balabanov, S; Soldini, D; Samaras, P; Gerber, B; Manz, M G; Goede, J G (2018). R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience. Annals of Hematology, 97(2):277-287.

Johansson, Patricia; Klein-Hitpass, Ludger; Choidas, Axel; Habenberger, Peter; Mahboubi, Bijan; Kim, Baek; Bergmann, Anke; Scholtysik, René; Brauser, Martina; Lollies, Anna; Siebert, Reiner; Zenz, Thorsten; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan (2018). SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia. Blood Cancer Journal, 8:11.

Parfejevs, Vadims; Debbache, Julien; Shakhova, Olga; Schaefer, Simon M; Glausch, Mareen; Wegner, Michael; Suter, Ueli; Riekstina, Una; Werner, Sabine; Sommer, Lukas (2018). Injury-activated glial cells promote wound healing of the adult skin in mice. Nature Communications:9:236.

Siebenhüner, Alexander R; Seifert, Heike; Bachmann, Helga; Seifert, Burkhardt; Winder, Thomas; Feilchenfeldt, Jonas; Breitenstein, Stefan; Clavien, Pierre-Alain; Stupp, Roger; Knuth, Alexander; Pestalozzi, Bernhard; Samaras, Panagiotis (2018). Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study. BMC Cancer, 18(1):72.

Soria, Jean-Charles; Ohe, Yuichiro; Vansteenkiste, Johan; Reungwetwattana, Thanyanan; Chewaskulyong, Busyamas; Lee, Ki Hyeong; Dechaphunkul, Arunee; Imamura, Fumio; Nogami, Naoyuki; Kurata, Takayasu; Okamoto, Isamu; Zhou, Caicun; Cho, Byoung Chul; Cheng, Ying; Cho, Eun Kyung; Voon, Pei Jye; Planchard, David; Su, Wu-Chou; Gray, Jhanelle E; Lee, Siow-Ming; Hodge, Rachel; Marotti, Marcelo; Rukazenkov, Yuri; Ramalingam, Suresh S; FLAURA Investigators (2018). Osimertinib in untreated EGFR-mutated advanced non–small-cell lung cancer. New England Journal of Medicine, 378(2):113-125.

Kerr, K M; et al; Bubendorf, L; Stahel, R A (2018). Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project. Annals of Oncology, 29(1):200-208.

Peters, Solange; Kerr, Keith M; Stahel, Rolf (2018). PD-1 blockade in advanced NSCLC: A focus on pembrolizumab. Cancer Treatment Reviews, 62:39-49.

Strickler, Nicole; Balabanov, Stefan; Casauro, Katharina; Schanz, Urs; Manz, Markus G; Gerber, Bernhard (2018). Acute central nervous system complications and ammonium levels in adult patients with acute lymphoblastic leukemia receiving l-asparaginase. Leukemia & Lymphoma, 59(4):855-862.

Guiducci, Eva; Lemberg, Christina; Küng, Noëmi; Schraner, Elisabeth; Theocharides, Alexandre P A; LeibundGut-Landmann, Salomé (2018). Candida albicans-Induced NETosis Is Independent of Peptidylarginine Deiminase 4. Frontiers in Immunology, 9:1573.

Bredell, Marius; Rordorf, Tamara; Kroiss, Sabine; Rücker, Martin; Zweifel, Daniel Fritz; Rostetter, Claudio (2018). Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study. Journal of Oral and Maxillofacial Surgery, 76(4):775-784.

Canella, Claudia; Mikolasek, Michael; Rostock, Matthias; Beyer, Jörg; Guckenberger, Matthias; Jenewein, Josef; Linka, Esther; Six, Claudia; Stoll, Sarah; Stupp, Roger; Witt, Claudia M (2018). Developing an integrative treatment program for cancer-related fatigue using stakeholder engagement - a qualitative study. Integrative cancer therapies, 17(3):762-773.

Wolpert, Fabian; Weller, Michael; Berghoff, Anna Sophie; Rushing, Elisabeth; Füreder, Lisa Michaela; Petyt, Gregory; Leske, Henning; Andratschke, Nicolaus; Regli, Luca; Neidert, Marian Christoph; Stupp, Roger; Stahel, Rolf; Dummer, Reinhard; Frauenfelder, Thomas; Roth, Patrick; Reyns, Nicolas; Kaufmann, Philipp Antonio; Preusser, Matthias; Le Rhun, Emilie (2018). Diagnostic value of 18 F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site. European Journal of Cancer, 96:64-72.

Dietrich, Sascha; et al; Rossi, Davide; Zenz, Thorsten (2018). Drug-perturbation-based stratification of blood cancer. Journal of Clinical Investigation, 128(1):427-445.

Letovanec, Igor; Finn, Stephen; Zygoura, Panagiota; Smyth, Paul; et al; Soltermann, Alex; Weder, Walter (2018). Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: results from the ETOP Lungscape Project. Journal of Thoracic Oncology, 13(3):413-425.

Silina, Karina; Soltermann, Alex; Movahedian Attar, Farkhondeh; Casanova, Ruben; Uckeley, Zina M; Thut, Helen; Wandres, Muriel; Isajevs, Sergejs; Cheng, Phil F; Curioni Fontecedro, Alessandra; Foukas, Periklis; Levesque, Mitchell P; Moch, Holger; Linē, Aija; van den Broek, Maries (2018). Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Research, 78(5):1308-1320.

Passweg, Jakob R; Baldomero, Helen; Ansari, Marc; Baerlocher, Gabriela M; Bargetzi, Mario; Chalandon, Yves; Duchosal, Michel A; Gerull, Sabine; Güngör, Tayfun; Halter, Jörg P; Heim, Dominik; Hess, Urs; Leibundgut, Kurt; Masouridi-Levrat, Stavroula; Müller, Antonia; Nair, Gayathri; Pabst, Thomas; Renner, Christoph; Schmidt, Adrian; Stussi, Georg; Nicoloso de Faveri, Grazia; Schanz, Urs (2018). Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016. Swiss Medical Weekly, 148:w14589.

Fankhauser, Christian D; Sander, S; Roth, Luzia; Beyer, Jörg; Hermanns, Thomas (2018). Improved survival in metastatic germ-cell cancer. Annals of Oncology, 29(2):347-351.

Franzen, Daniel; Schad, Karin; Kowalski, Benedikt; Clarenbach, Christian F; Stupp, Roger; Dummer, Reinhard; Kohler, Malcolm (2018). Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational study. Cancer Immunology, Immunotherapy, 67(1):127-134.

Oehl, Kathrin; Kresoja-Rakic, Jelena; Opitz, Isabelle; Vrugt, Bart; Weder, Walter; Stahel, Rolf; Wild, Peter; Felley-Bosco, Emanuela (2018). Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression. Frontiers in Oncology, 8:40.

Posch, Florian; Silina, Karina; Leibl, Sebastian; Mündlein, Axel; Moch, Holger; Siebenhüner, Alexander; Samaras, Panagiotis; Riedl, Jakob; Stotz, Michael; Szkandera, Joanna; Stöger, Herbert; Pichler, Martin; Stupp, Roger; van den Broek, Maries; Schraml, Peter; Gerger, Armin; Petrausch, Ulf; Winder, Thomas (2018). Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. OncoImmunology, 7(2):e1378844.

Samaras, Panagiotis; Rütti, Markus F; Seifert, Burkhardt; Bachmann, Helga; Schanz, Urs; Eisenring, Maya; Renner, Christoph; Müller, Antonia Maria; Schmidt, Adrian; Mischo, Axel; Fuchs, Ivo; Bargetzi, Mario; Manz, Markus G; Stupp, Roger; Petrausch, Ulf; Stenner-Liewen, Frank (2018). Mobilization of hematopoietic progenitor cells with standard or reduced dose filgrastim after vinorelbine in multiple myeloma patients. a randomized prospective single center phase II study. Biology of Blood and Marrow Transplantation, 24(4):694-699.

Singer, Jochen; Ruscheweyh, Hans-Joachim; Hofmann, Ariane L; Thurnherr, Thomas; Singer, Franziska; Toussaint, Nora C; Ng, Charlotte K Y; Piscuoglio, Salvatore; Beisel, Christian; Christofori, Gerhard; Dummer, Reinhard; Hall, Michael N; Krek, Wilhelm; Levesque, Mitchell; Manz, Markus G; Moch, Holger; Papassotiropoulos, Andreas; Stekhoven, Daniel J; Wild, Peter; Wüst, Thomas; Rinn, Bernd; Beerenwinkel, Niko (2018). NGS-pipe: a flexible, easily extendable, and highly configurable framework for NGS analysis. Bioinformatics, 34(1):107-108.

Fankhauser, Christian D; Grossmann, Nico C; Beyer, Joerg; Hermanns, Thomas (2018). Re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary treatment patterns and outcomes for clinical stage IS testicular cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.06.013. European Urology, 73(4):e94-e95.

Rechsteiner, Markus; Dedes, Konstantin; Fink, Daniel; Pestalozzi, Bernhard; Sobottka, Bettina; Moch, Holger; Wild, Peter; Varga, Zsuzsanna (2018). Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features. Journal of Cancer Research and Clinical Oncology, 144(5):865-874.

Stein, Philipp; Studt, Jan-Dirk; Albrecht, Roland; Müller, Stefan; von Ow, Dieter; Fischer, Simon; Seifert, Burkhardt; Mariotti, Sergio; Spahn, Donat R; Theusinger, Oliver M (2018). The Impact of Prehospital Tranexamic Acid on Blood Coagulation in Trauma Patients. Anesthesia and Analgesia, 126(2):522-529.

Arnold, Isabelle C; Zhang, Xiaozhou; Urban, Sabine; Artola-Borán, Mariela; Manz, Markus G; Ottemann, Karen M; Müller, Anne (2017). NLRP3 Controls the Development of Gastrointestinal CD11b+ Dendritic Cells in the Steady State and during Chronic Bacterial Infection. Cell Reports, 21(13):3860-3872.

Rongvaux, A; Willinger, T; Martinek, J; Strowig, T; Gearty, SV; Teichmann, LL; Saito, Y; Marches, F; Halene, S; Palucka, AK; Manz, MG; Flavell, RA (2017). Corrigendum: Development and function of human innate immune cells in a humanized mouse model. Nature Biotechnology, 35(12):1211.

Cornely, Oliver A; Robertson, Michael N; Haider, Shariq; Grigg, Andrew; Geddes, Michelle; Aoun, Mickael; Heinz, Werner J; Raad, Issam; Schanz, Urs; Meyer, Ralf G; Hammond, Sarah P; Mullane, Kathleen M; Ostermann, Helmut; Ullmann, Andrew J; Zimmerli, Stefan; Van Iersel, M L P S; Hepler, Deborah A; Waskin, Hetty; Kartsonis, Nicholas A; Maertens, Johan (2017). Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. Journal of Antimicrobial Chemotherapy, 72(12):3406-3413.

Gerull, S; Denhaerynck, K; Chalandon, Y; Halter, J P; Kirsch, M; Kiss, A; Schanz, U; Vu, D L; De Geest, S; Passweg, J (2017). Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study. Bone Marrow Transplantation, 52(12):1686-1688.

Datta, Niloy Ranjan; Pestalozzi, Bernhard; Clavien, Pierre-Alain; Siebenhüner, Alexander; Puric, Emsad; Khan, Shaka; Mamot, Christoph; Riesterer, Oliver; Knuchel, Jürg; Reiner, Cäcilia Sophie; Bodis, Stephan; HEATPAC Trial Group (2017). "HEATPAC" - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer. Radiation Oncology, 12(1):183.

Widmer, C C; Balabanov, S; Schanz, U; Theocharides, A (2017). Transient paraproteinemia after allogeneic hematopoietic stem cell transplantation is an underexplored phenomenon associated with graft versus host disease. OncoTarget, 8(63):106333-106341.

Müller, Antonia M. Friend or foe? – donor t cells regulate hematopoietic stem-cell and immune function following allogeneic hematopoietic cell transplantation. 2017, University of Zurich, Faculty of Medicine.

Widmer, Fabienne. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-Center experience. 2017, University of Zurich, Faculty of Medicine.

Lysenko, Veronika; McHugh, Donal; Behrmann, Lena; Rochat, Mary-Aude; Wilk, Christian M; Kovtonyuk, Larisa V; Bourquin, Jean-Pierre; Münz, Christian; Manz, Markus G; Speck, Roberto F; Theocharides, Alexandre P (2017). Humanised mouse models for haematopoiesis and infectious diseases. Swiss Medical Weekly, 147:w14516.

Ashcroft, Peter; Manz, Markus G; Bonhoeffer, Sebastian (2017). Clonal dominance and transplantation dynamics in hematopoietic stem cell compartments. PLoS Computational Biology, 13(10):e1005803.

Bobrowicz, Malgorzata; Dwojak, Michal; Pyrzynska, Beata; et al (2017). HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies. Blood, 130(14):1628-1638.

Samaras, Panagiotis; Tusup, Marina; Nguyen-Kim, Thi Dan Linh; Seifert, Burkhardt; Bachmann, Helga; von Moos, Roger; Knuth, Alexander; Pascolo, Steve (2017). Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer. Cancer Chemotherapy and Pharmacology, 80(5):1005-1012.

Cohn, C S; Dumont, L J; Lozano, M; et al; Schanz, U (2017). Vox Sanguinis International Forum on platelet cryopreservation. Vox sanguinis, 112(7):e69-e85.

Cohn, C S; Dumont, L J; Lozano, M; et al; Schanz, U (2017). Vox Sanguinis International Forum on platelet cryopreservation: Summary. Vox sanguinis, 112(7):684-688.

Jud, Stéphanie. sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-α therapy. 2017, University of Zurich, Faculty of Medicine.

Reding, Daniel; Pestalozzi, Bernhard Cornelius; Breitenstein, Stefan; Stupp, Roger; Clavien, Pierre-Alain; Slankamenac, Ksenija; Samaras, Panagiotis (2017). Treatment strategies and outcome of surgery for synchronous colorectal liver metastases. Swiss Medical Weekly, 147:w14486.

Rupp, Niels J; Mischo, Axel; Moch, Holger (2017). Neue und vielversprechende molekulare Therapieoptionen in verschiedenen Subtypen des Nierenzellkarzinoms. Therapeutische Umschau. Revue thérapeutique, 74(4):171-179.

Pasi, K J; Rangarajan, S; Georgiev, P; Mant, T; Creagh, M D; Lissitchkov, T; Bevan, D; Austin, S; Hay, C R; Hegemann, I; Kazmi, R; Chowdary, P; Gercheva-Kyuchukova, L; Mamonov, V; Timofeeva, M; Soh, C H; Garg, P; Vaishnaw, A; Akinc, A; Sorenson, B; Ragni, M V (2017). Targeting of antithrombin in hemophilia A or B with RNAi therapy. New England Journal of Medicine, 377(9):819-828.

Hashwah, Hind; Schmid, Corina A; Kasser, Sabrina; Bertram, Katrin; Stelling, Anna; Manz, Markus G; Müller, Anne (2017). Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth. Proceedings of the National Academy of Sciences of the United States of America, 114(36):9701-9706.

Wilk, C Matthias; Weber, Isabel; Seidl, Kati; Rachmühl, Carole; Holzmann-Bürgel, Anne; Müller, Antonia M S; Kuster, Stefan P; Schanz, Urs; Zinkernagel, Annelies S (2017). Impact of oral gut decontamination on staphylococcus aureus colonization in patients undergoing allogeneic hematopoietic stem cell transplantation. International Journal of Antimicrobial Agents, 50(6):726-729.

Takizawa, Hitoshi; Fritsch, Kristin; Kovtonyuk, Larisa V; Saito, Yasuyuki; Yakkala, Chakradhar; Jacobs, Kurt; Ahuja, Akshay K; Lopes, Massimo; Hausmann, Annika; Hardt, Wolf-Dietrich; Gomariz, Álvaro; Nombela-Arrieta, César; Manz, Markus G (2017). Pathogen-induced TLR4-TRIF innate immune signaling in hematopoietic stem cells promotes proliferation but reduces competitive fitness. Cell Stem Cell, 21(2):225-240.e5.

Curioni-Fontecedro, Alessandra; Ickenberg, C; Franzen, D; Rogler, Gerhard; Burger, Irene A; van den Broek, M (2017). Diffuse pseudoprogression in a patient with metastatic non-small-cell lung cancer treated with Nivolumab. Annals of Oncology, 28(8):2040-2041.

Studt, J D; Alberio, L; Angelillo-Scherrer, A; Asmis, L M; Fontana, P; Korte, W; Mendez, A; Schmid, P; Stricker, H; Tsakiris, D A; Wuillemin, W A; Nagler, Michael (2017). Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels. Journal of Thrombosis and Haemostasis, 15(8):1576-1583.

Seifert, Heike; Siebenhüner, Alexander (2017). CME-Antworten zu den Fragen zu «Früherkennung Brustkrebs – Stellenwert der Screening-Mammografie anhand eines Fallbeispiels» aus Praxis Nr. 14. Praxis, 106(15):845.

Bulla, O; Poncet, A; Albeiro, L; Asmis, L M; Gähler, A; Graf, L; Nagler, M; Studt, J D; Tsakiris, D A; Fontana, P (2017). Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study. Haemophilia, 23(4):e335-e339.

Takizawa, Hitoshi; Manz, Markus G (2017). Impact of inflammation on early hematopoiesis and the microenvironment. International Journal of Hematology, 106(1):27-33.

Dyshlovoy, Sergey A; Otte, Katharina; Venz, Simone; Hauschild, Jessica; Junker, Heike; Makarieva, Tatyana N; Balabanov, Stefan; Alsdorf, Winfried H; Madanchi, Ramin; Honecker, Friedemann; Bokemeyer, Carsten; Stonik, Valentin A; von Amsberg, Gunhild (2017). Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin. Proteomics, 17(11):1700048.

Lorch, Anja; Beyer, Jörg (2017). How we treat germ cell cancers. Cancer, 123(12):2190-2192.

Onida, Francesco; de Wreede, Liesbeth C; van Biezen, Anja; et al; Schanz, Urs; Chalandon, Yves (2017). Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. British Journal of Haematology, 177(5):759-765.

Rostetter, Claudio; Rordorf, Tamara; Essig, Harald; Zweifel, Daniel; Schumann, Paul; Rücker, Martin; Bredell, Marius (2017). Neuer Therapieansatz mit Denosumab bei Riesenzellgranulomen. Ein Fallbeispiel. Swiss Dental Journal, 127(6):520-521.

Audigé, Annette; Rochat, Mary-Aude; Li, Duo; Ivic, Sandra; Fahrny, Audrey; Muller, Christina K S; Gers-Huber, Gustavo; Myburgh, Renier; Bredl, Simon; Schlaepfer, Erika; Scherrer, Alexandra U; Kuster, Stefan P; Speck, Roberto F (2017). Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells. BMC Immunology, 18(1):28.

Gerosa, Rahel. The regulatory role of non-hematopoietic bone marrow cells on hematopoiesis in steady-state and inflammation. 2017, University of Zurich, Faculty of Science.

Rosell, Rafael; Dafni, Urania; Felip, Enriqueta; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Peters, Solange; Massutí, Bartomeu; Palmero, Ramon; Aix, Santiago Ponce; Carcereny, Enric; Früh, Martin; Pless, Miklos; Popat, Sanjay; Kotsakis, Athanasios; Cuffe, Sinead; Bidoli, Paolo; Favaretto, Adolfo; Froesch, Patrizia; Reguart, Noemí; Puente, Javier; Coate, Linda; Barlesi, Fabrice; Rauch, Daniel; Thomas, Michael; Camps, Carlos; Gómez-Codina, Jose; Majem, Margarita; Porta, Rut; Shah, Riyaz; Hanrahan, Emer; et al (2017). Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. Lancet Respiratory Medicine, 5(5):435-444.

Fontana, Pierre; Alberio, Lorenzo; Angelillo-Scherrer, Anne; Asmis, Lars M; Korte, Wolfgang; Mendez, Adriana; Schmid, Pirmin; Stricker, Hans; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Wuillemin, Walter A; Nagler, Michael (2017). Impact of rivaroxaban on point-of-care assays. Thrombosis research, 153:65-70.

Pestalozzi, Bernhard C; Tausch, Christoph; Dedes, Konstantin J; Rochlitz, Christoph; Zimmermann, Stefan; von Moos, Roger; Winterhalder, Ralph; Ruhstaller, Thomas; Mueller, Andreas; Buser, Katharina; Borner, Markus; Novak, Urban; Nussbaum, Catrina Uhlmann; Seifert, Bettina; Bigler, Martin; Bize, Vincent; Vilei, Simona Berardi; Rageth, Christoph; Aebi, Stefan; Swiss Group for Clinical Cancer Research (SAKK) (2017). Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). BMC Cancer, 17(1):265.

Parrotta, Rossella; Okonska, Agata; Ronner, Manuel; Weder, Walter; Stahel, Rolf; Penengo, Lorenza; Felley-Bosco, Emanuela (2017). A novel BRCA1-associated protein-1 isoform affects response of mesothelioma cells to drugs impairing BRCA1-mediated DNA repair. Journal of Thoracic Oncology, 12(8):1309-1319.

Zhu, Haiyan; Kwak, Hyun-Jeong; Liu, Peng; Bajrami, Besnik; Xu, Yuanfu; Park, Shin-Young; Nombela-Arrieta, Cesar; Mondal, Subhanjan; Kambara, Hiroto; Yu, Hongbo; Chai, Li; Silberstein, Leslie E; Cheng, Tao; Luo, Hongbo R (2017). Reactive Oxygen Species-Producing Myeloid Cells Act as a Bone Marrow Niche for Sterile Inflammation-Induced Reactive Granulopoiesis. Journal of Immunology, 198(7):2854-2864.

González-Billalabeitia, Enrique; Sepúlveda, Juan Manuel; Maroto, Pablo; Aparicio, Jorge; Arranz, Jose Angel; Esteban, Emilio; Gironés, Regina; López-Brea, Marta; Mendez-Vidal, María José; Pinto, Alvaro; Sastre, Javier; de Prado, Diego Soto; Terrasa, Josefa; Vázquez, Sergio; Powles, Thomas; Beyer, Jörg; Castellano, Daniel; Del Muro, Xavier García; Spanish Germ Cell Cancer Group and the Spanish Oncology Genitour (2017). Consensus recommendations from the spanish germ cell cancer group on the use of high-dose chemotherapy in germ cell cancer. European Urology Focus, 3(2-3):280-286.

Valenta, Sabine; De Geest, Sabina; Fierz, Katharina; Beckmann, Sonja; Halter, Jörg; Schanz, Urs; Nair, Gayathri; Kirsch, Monika (2017). Perception of late effects among long-term survivors after haematopoietic stem cell transplantation: Descriptive analysis and validation of the Brief Illness Perception Questionnaire. A sub-study of the PROVIVO study. European Journal of Oncology Nursing, 27:17-27.

Wehrli, M; Oppliger Leibundgut, E; Gattiker, H H; Manz, Markus G; Müller, A M; Goede, J S (2017). Response to tyrosine kinase hnhibitors in myeloproliferative neoplasia with 8p11 translocation and CEP110-FGFR1 rearrangement. The Oncologist, 22(4):480-483.

Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; van Norden, Yvette; Biemond, Bart J; Schouten, Harry C; Spertini, Olivier; Vellenga, Edo; Graux, Carlos; Havelange, Violaine; de Greef, Georgine E; de Weerdt, Okke; Legdeur, Marie-Cecile J C; Kuball, Juergen; van Marwijk Kooy, Marinus; Gjertsen, Bjorn T; Jongen-Lavrencic, Mojca; van de Loosdrecht, Arjan A; van Lammeren-Venema, Daniëlle; Hodossy, Beata; Breems, Dimitri A; Chalandon, Yves; Passweg, Jakob; Valk, Peter J M; Manz, Markus G; Ossenkoppele, Gert J (2017). Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML. Blood, 129(12):1636-1645.

Baumgartner, Annic; Bargetzi, Mario; Bargetzi, Annika; Zueger, Noemi; Medinger, Micheal; Passweg, Jakob; Schanz, Urs; Samaras, Panagiotis; Chalandon, Yves; Pichard, Claude; Limonta, Alessandro; Wannesson, Luciano; Pabst, Thomas; Duchosal, Michel A; Hess, Urs; Stanga, Zeno; Mueller, Beat; Schuetz, Philipp (2017). Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison. Nutrition, 35:43-50.

Gachechiladze, Mariam; Škarda, Josef; Kolek, Vítězslav; Grygárková, Ivona; Langová, Kateřina; Bouchal, Jan; Kolář, Zdeněk; Baty, Florent; Stahel, Rolf; Weder, Walter; Soltermann, Alex; Joerger, Markus (2017). Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients. Lung Cancer, 105:31-38.

Yu, Hua; Borsotti, Chiara; Schickel, Jean-Nicolas; Zhu, Shu; Strowig, Till; Enyon, Elizabeth E; Frleta, Davor; Gurer, Cagan; Murphy, Andrew J; Yancopoulos, George D; Meffre, Eric; Manz, Markus G; Flavell, Richard A (2017). A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production. Blood, 129(8):959-969.

Parrinello, Natalia. Cellular consequences of loss of eukaryiotic translation initiation factor 5A in eukaryiotic cells. 2017, University of Zurich, Faculty of Science.

Nombela-Arrieta, C; Manz, M G (2017). Quantification and three-dimensional microanatomical organization of the bone marrow. Blood advances, 1(6):407-416.

Fritsch, Kristin. Hematopoietic stem cell maintenance in steady-state and inflammation. 2017, University of Zurich, Faculty of Science.

Kostron, Arthur; Friess, Martina; Inci, Ilhan; Hillinger, Sven; Schneiter, Didier; Gelpke, Hans; Stahel, Rolf; Seifert, Burkhardt; Weder, Walter; Opitz, Isabelle (2017). Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients. Interactive Cardiovascular and Thoracic Surgery, 24(5):740-746.

Datta, Niloy Ranjan; Stutz, Emanuel; Liu, Michael; Rogers, Susanne; Klingbiel, Dirk; Siebenhüner, Alexander; Singh, Shalini; Bodis, Stephan (2017). Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis. Gynecologic Oncology, 145(2):374-385.

Pagani, O; Klingbiel, D; Ruhstaller, T; Nolè, F; Eppenberger, S; Oehlschlegel, C; Bernhard, J; Brauchli, P; Hess, D; Mamot, C; Munzone, E; Pestalozzi, B; Rabaglio, M; Aebi, S; Ribi, K; Rochlitz, C; Rothgiesser, K; Thürlimann, B; Moos, R von; Zaman, K; Goldhirsch, A; Swiss Group for Clinical Cancer Research (SAKK) (2017). Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized Phase III trial SAKK 22/99. Annals of Oncology, 28(2):305-312.

Gössi, F; Spahn, M; Zweifel, M; Panagiotis, S; Mischo, A; Stenner, F; Hess, U; Berthold, D; Bargetzi, M; Schardt, J; Pabst, T (2017). Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse. Bone Marrow Transplantation, 52(2):334-336.

Maul, Julia-Tatjana; Stenner-Liewen, Frank; Seifert, Burkhardt; Pfrommer, Sarah; Petrausch, Ulf; Kiessling, Michael K; Schanz, Urs; Nair, Gayathri; Mischo, Axel; Taverna, Christian; Schmidt, Adrian; Bargetzi, Mario; Stupp, Roger; Renner, Christoph; Samaras, Panagiotis (2017). Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients. Journal of clinical apheresis, 32(1):21-26.

Bonadies, Nicolas; Feller, Anita; Rovo, Alicia; Ruefer, Axel; Blum, Sabine; Gerber, Bernhard; Stuessi, Georg; Benz, Rudolf; Cantoni, Nathan; Holbro, Andreas; Schmidt, Adrian; Lehmann, Thomas; Wilk, C Matthias; Arndt, Volker; NICER Working Group (2017). Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012. Cancer Epidemiology, 46:85-92.

Bringolf, Lilian; Pestalozzi, Bernhard; Fink, Daniel; Dedes, Konstantin (2017). Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital. Swiss Medical Weekly, 146:w14393.

Fischer, Stefanie; Tandstad, Torgrim; Wheater, Matthew; Porfiri, Emilio; Fléchon, Aude; Aparicio, Jorge; Klingbiel, Dirk; Skrbinc, Breda; Basso, Umberto; Shamash, Jonathan; Lorch, Anja; Dieckmann, Klaus-Peter; Cohn-Cedermark, Gabriella; Ståhl, Olof; Chau, Caroline; Arriola, Edurne; Marti, Kalena; Hutton, Paul; Laguerre, Brigitte; Maroto, Pablo; Beyer, Jörg; Gillessen, Silke (2017). Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma. Journal of Clinical Oncology, 35(2):194-200.

von Moos, Roger; Costa, Luis; Ripamonti, Carla Ida; Niepel, Daniela; Santini, Daniele (2017). Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain. European Journal of Cancer, 71:80-94.

Meissner, J; Finel, H; Dietrich, S; Boumendil, A; Kanfer, E; Laboure, G; Abecasis, M; Cornelissen, J; Delage, J; Finke, J; Hess, U; Ludwig, H; Mohty, M; Pabst, T; Pioltelli, P; Robinson, S; Samaras, P; Montoto, S; Dreger, P (2017). Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone Marrow Transplantation, 52(4):650-652.

Gautschi, Oliver; Rothschild, Sacha I; Li, Qiyu; Matter-Walstra, Klazien; Zippelius, Alfred; Betticher, Daniel C; Früh, Martin; Stahel, Rolf A; Cathomas, Richard; Rauch, Daniel; Pless, Miklos; Peters, Solange; Froesch, Patrizia; Zander, Thilo; Schneider, Martina; Biaggi, Christine; Mach, Nicolas; Ochsenbein, Adrian F; Swiss Group for Clinical Cancer Research (SAKK) (2017). Bevacizumab plus pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous non-small-cell lung cancer: Update from the swiss group for clinical cancer research (SAKK) 19/09 trial. Clinical Lung Cancer, 18(3):303-309.

Fridle, Chantal; Medinger, Michael; Wilk, Matthias C; Seipel, Katja; Passweg, Jakob; Manz, Markus G; Pabst, Thomas (2017). Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML). Leukemia & Lymphoma, 58(5):1068-1075.

Filipa Gonçalves, Ana; Adlesic, Mojca; Brandt, Simone; Hejhal, Tomas; Harlander, Sabine; Sommer, Lukas; Shakhova, Olga; Wild, Peter J; Frew, Ian J (2017). Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells. Nature Communications, 8(1):1466.

Lorch, Anja; Beyer, Jörg (2017). High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how. World Journal of Urology, 35(8):1177-1184.

Vavassori, Stefano; Galson, Jacob D; Trück, Johannes; van den Berg, Anke; Tamminga, Rienk Y J; Magerus-Chatinet, Aude; Pellé, Olivier; Camenisch Gross, Ulrike; Marques Maggio, Ewerton; Prader, Seraina; Opitz, Lennart; Nüesch, Ursina; Mauracher, Andrea A; Volkmer, Benjamin; Speer, Oliver; Suda, Luzia; Röthlisberger, Benno; Zimmermann, Dieter Robert; Müller, Rouven; Diepstra, Arjan; Visser, Lydia; Haralambieva, Eugenia; Neven, Benedicte; Rieux-Laucat, Frédéric; Pachlopnik Schmid, Jana (2017). Lymphadenopathy driven by TCR-Vγ8Vδ1 T-cell expansion in FAS-related autoimmune lymphoproliferative syndrome. Blood advances, 1(15):1101-1106.

Tsioptsias, Costas; Lionta, Gesthimani; Samaras, Petros (2017). Microalgae-activated sludge treatment of molasses wastewater in sequencing batch photo-bioreactor. Environmental Technology, 38(9):1120-1126.

Kresoja-Rakic, Jelena; Sulemani, Merve; Kirschner, Michaela B; Ronner, Manuel; Reid, Glen; Kao, Steven; Schwaller, Beat; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2017). Posttranscriptional regulation controls calretinin expression in malignant pleural mesothelioma. Frontiers in Genetics, 8:70.

Bubendorf, Lukas; Dafni, Urania; Schöbel, Martin; Finn, Stephen P; Tischler, Verena; Sejda, Aleksandra; Marchetti, Antonio; Thunnissen, Erik; Verbeken, Eric K; Warth, Arne; Sansano, Irene; Cheney, Richard; Speel, Ernst Jan M; Nonaka, Daisuke; Monkhorst, Kim; Hager, Henrik; Martorell, Miguel; Savic, Spasenija; Kerr, Keith M; Tan, Qiang; Tsourti, Zoi; Geiger, Thomas R; Kammler, Roswitha; Schulze, Katja; Das-Gupta, Ashis; Shames, David; Peters, Solange; Stahel, Rolf A (2017). Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: results from the European Thoracic Oncology Platform (ETOP) Lungscape project. Lung Cancer, 111:143-149.

Theusinger, Oliver M; Goslings, David; Studt, Jan-Dirk; Brand-Staufer, Brigitte; Seifert, Burkhardt; Spahn, Donat R; Frey, Beat M (2017). Quarantine versus pathogen-reduced plasma-coagulation factor content and rotational thromboelastometry coagulation. Transfusion, 57(3):637-645.

Peters, Solange; Stahel, Rolf A; Dafni, Urania; Aix, Santiago Ponce; Massutí, Bartomeu; Gautschi, Oliver; Coate, Linda; López Martín, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Noguera, Javier Garde; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen Mj; Vidal, Óscar Juan; Sanchez, Ramón Palmero; Villa Guzmán, José Carlos; Martin, Ricardo Collado; Peralta, Sergio; Insa, Amelia; Summers, Yvonne; Láng, István; Horgan, Anne; Ciardiello, Fortunato; de Hosson, Sander; et al (2017). Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. Journal of Thoracic Oncology, 12(4):752-762.

Boettcher, Steffen; Manz, Markus G (2017). Regulation of inflammation- and infection-driven hematopoiesis. Trends in Immunology, 38(5):345-357.

Bezan, Angelika; Posch, Florian; Ploner, Ferdinand; Bauernhofer, Thomas; Pichler, Martin; Szkandera, Joanna; Hutterer, Georg C; Pummer, Karl; Gary, Thomas; Samonigg, Hellmut; Beyer, Joerg; Winder, Thomas; Hermanns, Thomas; Fankhauser, Christian D; Gerger, Armin; Stotz, Michael (2017). Risk stratification for venous thromboembolism in patients with testicular germ cell tumors. PLoS ONE, 12(4):e0176283.

Negrouk, Anastassia; Lacombe, Denis; Cardoso, Fatima; Morin, Franck; Carrasco, Eva; Maurel, Joan; Maibach, Rudolf; Aranda, Enrique; Marais, Richard; Stahel, Rolf A (2017). Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients. ESMO Open, 2(3):e000187.

Jud, Stéphanie; Goede, Jeroen S; Senn, Oliver; Spanaus, Katharina; Manz, Markus G; Benz, Rudolf (2017). sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-α therapy. Annals of Hematology, 96(5):757-763.

Dyshlovoy, S A; Menchinskaya, E S; Venz, S; Rast, S; et al (2016). The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer. International Journal of Cancer, 138(10):2450-2465.

Kroeze, Stephanie G C; Fritz, Corinna; Hoyer, Morten; Lo, Simon S; Ricardi, Umberto; Sahgal, Arjun; Stahel, Rolf; Stupp, Roger; Guckenberger, Matthias (2016). Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review. Cancer Treatment Reviews, 53:25-37.

Vegro, Mara; Eccher, Giulia; Populin, Francesca; Sorgato, Chiara; Savazzini, Federica; Pagliarani, Giulia; Tartarini, Stefano; Pasini, Gabriella; Curioni, Andrea; Antico, Andrea; Botton, Alessandro (2016). Old apple (malus domestica L. Borkh) varieties with hypoallergenic properties: an integrated approach for studying apple allergenicity. Journal of Agricultural and Food Chemistry, 64(48):9224-9236.

Tsioptsias, Costas; Lionta, Gesthimani; Deligiannis, Andreas; Samaras, Petros (2016). Enhancement of the performance of a combined microalgae-activated sludge system for the treatment of high strength molasses wastewater. Journal of environmental management, 183(1):126-32.

Kovtonyuk, L; Fritsch, K; Feng, X; Manz, M G; Takizawa, H (2016). Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment. Frontiers in Immunology, 7:502.

Rauch, P J; Ellegast, J M; Widmer, C C; Fritsch, K; Goede, J S; Valk, P J; Löwenberg, B; Takizawa, H; Manz, M G (2016). MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia. Blood, 128(18):2253-2257.

Reijneveld, Jaap C; Taphoorn, Martin J B; Coens, Corneel; Bromberg, Jacoline E C; Mason, Warren P; Hoang-Xuan, Khê; Ryan, Gail; Hassel, Mohamed Ben; Enting, Roelien H; Brandes, Alba A; Wick, Antje; Chinot, Olivier; Reni, Michele; Kantor, Guy; Thiessen, Brian; Klein, Martin; Verger, Eugenie; Borchers, Christian; Hau, Peter; Back, Michael; Smits, Anja; Golfinopoulos, Vassilis; Gorlia, Thierry; Bottomley, Andrew; Stupp, Roger; Baumert, Brigitta G (2016). Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1533-1542.

Das, R; Srowig, T; Verma, R; Koduru, S; Hafemann, A; Hopf, S; Kocoglu, M H; Borsotti, C; Zhang, L; Branagan, A; Eynon, E; Manz, M G; Flavell, R A; Dhodapkar, M V (2016). Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice. Nature Medicine, 22(11):1351-1357.

Hart, C; Klatt, S; Barop, J; Müller, G; Schelker, R; Holler, E; Huber, E; Herr, W; Grassinger, J (2016). Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation. Haematologica, 101(11):1407-1416.

Baumert, Brigitta G; Hegi, Monika E; van den Bent, Martin J; von Deimling, Andreas; Gorlia, Thierry; Hoang-Xuan, Khê; Brandes, Alba A; Kantor, Guy; Taphoorn, Martin J B; Hassel, Mohamed Ben; Hartmann, Christian; Ryan, Gail; Capper, David; Kros, Johan M; Kurscheid, Sebastian; Wick, Wolfgang; Enting, Roelien; Reni, Michele; Thiessen, Brian; Dhermain, Frederic; Bromberg, Jacoline E; Feuvret, Loic; Reijneveld, Jaap C; Chinot, Olivier; Gijtenbeek, Johanna M M; Rossiter, John P; Dif, Nicolas; Balana, Carmen; Bravo-Marques, Jose; Clement, Paul M; et al (2016). Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1521-1532.

Ellegast, J M; Rauch, P J; Kovtonyuk, L V; Müller, R; Wagner, U; Saito, Y; Wildner-Verhey van Wijk, N; Fritz, C; Rafiei, A; Lysenko, V; Dudkiewicz, E; Theocharides, A P; Soldini, D; Goede, J S; Flavell, R A; Manz, M G (2016). inv(16) and NPM1$^{mut}$ AMLs engraft human cytokine knock-in mice. Blood, 128(17):2130-2134.

Limani, Perparim; Linecker, Michael; Kron, Philipp; Samaras, Panagiotis; Pestalozzi, Bernhard; Stupp, Roger; Jetter, Alexander; Dutkowski, Philipp; Müllhaupt, Beat; Schlegel, Andrea; Nicolau, Claude; Lehn, Jean-Marie; Petrowsky, Henrik; Humar, Bostjan; Graf, Rolf; Clavien, Pierre-Alain (2016). Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial. BMC Cancer, 16(1):812.

Ernst, Jutta; Ikenberg, Kristian; Apel, Barbara; Schumann, Desiree M; Huber, Gerhard; Studer, Gabriela; Rordorf, Tamara; Riesterer, Oliver; Rössle, Matthias; Korol, Dimitri; Bredell, Marius G (2016). Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue. OncoTarget, 7(46):76151-76158.

Lukamowicz-Rajska, Magdalena; Mittmann, Christiane; Prummer, Michael; Zhong, Qing; Bedke, Jens; Hennenlotter, Jörg; Stenzl, Arnulf; Mischo, Axel; Bihr, Svenja; Schmidinger, Manuela; Vogl, Ursula; Blume, Iris; Karlo, Christoph; Schraml, Peter; Moch, Holger (2016). MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients. OncoTarget:15.

Luis, T C; Tremblay, C S; Manz, M G; North, T E; King, K Y; Challen, G A (2016). Inflammatory signals in HSPC development and homeostasis: Too much of a good thing? Experimental Hematology, 44(10):908-912.

Gerber, B; Alberio, L; Rochat, S; Stenner, F; Manz, M G; Buser, A; Schanz, U; Stussi, G (2016). Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies. Transfusion, 56(10):2426-2437.

Hottinger, Andreas F; Pacheco, Patricia; Stupp, Roger (2016). Tumor treating fields: a novel treatment modality and its use in brain tumors. Neuro-Oncology, 18(10):1338-1349.

Bajrami, B; Zhu, H; Kwak, H J; Mondal, S; Hou, Q; Geng, G; Keratepe, K; Zhang, Y C; Nombela-Arrieta, C; Park, S Y; Loison, F; Sakai, J; Xu, Y; Silberstein, L E; Luo, H R (2016). G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling. Journal of Experimental Medicine, 213(10):1999-2018.

Roodakker, Kenney R; Elsir, Tamador; Edqvist, Per-Henrik D; Hägerstrand, Daniel; Carlson, Joseph; Lysiak, Malgorzata; Henriksson, Roger; Pontén, Fredrik; Rosell, Johan; Söderkvist, Peter; Stupp, Roger; Tchougounova, Elena; Nistér, Monica; Malmström, Annika; Smits, Anja (2016). PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. OncoTarget, 7(45):72431-72442.

Sorrentino, Simona; Studt, Jan-Dirk; Horev, Melanie Bokstad; Medalia, Ohad; Sapra, K Tanuj (2016). Toward correlating structure and mechanics of platelets. Cell Adhesion & Migration, 10(5):568-575.

Happold, C; Gorlia, T; Chinot, O; Gilbert, M R; Nabors, L B; Wick, W; Pugh, S L; Hegi, M; Cloughesy, T; Roth, P; Reardon, D A; Perry, J R; Mehta, M P; Stupp, R; Weller, M (2016). Reply to F. Felix et al and M.F. Fay et al. Journal of Clinical Oncology, 34(25):3107-3108.

Koenecke, C; Heim, D; van Biezen, A; Heuser, M; Aljurf, M; Kyrcz-Krzemien, S; Volin, L; De Souza, C A; Gedde-Dahl, T; Sengeloev, H; Schanz, U; Komarnicki, M; Arroyo, C H; Tholouli, E; Gluckman, E; Esquirol, A; Yakoub-Agha, I; Gürman, G; Olavarria, E; Kröger, N (2016). Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy: A report from the EBMT Chronic Malignancies Working Party. Bone Marrow Transplantation, 51(9):1259-1261.

Piegeler, Tobias; Winder, Thomas; Kern, Sabine; Pestalozzi, Bernhard; Schneider, Paul Magnus; Beck-Schimmer, Beatrice (2016). Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch(®) system: An observational feasibility study. Oncology Letters, 12(2):1513-1518.

Dittrich, C; Kosty, M; Jezdic, S; Pyle, D; Berardi, R; Bergh, J; El-Saghir, Nagi; Lotz, J-P; Österlund, P; Pavlidis, N; Purkalne, G; ESMO/ASCO (2016). ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016. Annals of Oncology, 27(8):1378-1381.

Brown, Michelle L; Glanzmann, Christoph; Huber, Gerhard; Bredell, Marius; Rordorf, Tamara; Studer, Gabriela (2016). IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80. Strahlentherapie und Onkologie, 192(8):526-536.

Saito, Y; Ellegast, J M; Rafiei, A; Song, Y; Kull, D; Heikenwalder, M; Rongvaux, A; Halene, S; Flavell, R A; Manz, M G (2016). Peripheral blood CD34$^+$ cells efficiently engraft human cytokine knock-in mice. Blood, 128(14):1829-1833.

Hitz, Felicitas; Zucca, Emanuele; Pabst, Thomas; Fischer, Natalie; Cairoli, Anne; Samaras, Panagiotis; Caspar, Clemens B; Mach, Nicolas; Krasniqi, Fatime; Schmidt, Adrian; Rothermundt, Christian; Enoiu, Milica; Eckhardt, Katrin; Berardi Vilei, Simona; Rondeau, Stephanie; Mey, Ulrich (2016). Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. British Journal of Haematology, 174(2):255-263.

Meerang, Mayura; Bérard, Karima; Friess, Martina; Bitanihirwe, Byron K Y; Soltermann, Alex; Vrugt, Bart; Felley-Bosco, Emanuela; Bueno, Raphael; Richards, William G; Seifert, Burkhardt; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2016). Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma. Molecular Oncology, 10(8):1255-1265.

Kovtonyuk, L V; Manz, M G; Takizawa, H (2016). Enhanced thrombopoietin but not G-CSF receptor stimulation induces self-renewing hematopoietic stem cell divisions in vivo. Blood, 127(25):3175-3179.

Stupp, Roger; Toms, Steven A; Kesari, Santosh (2016). Treatment for patients with newly diagnosed glioblastoma--reply. JAMA : the Journal of the American Medical Association, 315(21):2348-2349.

Pietras, E M; Mirantes-Barbeito, C; Fong, S; Loeffler, D; Kovtonyuk, L V; Zhang, S; Lakshminarasimhan, R; Chin, C P; Techner, J M; Will, B; Nerlov, C; Steidl, U; Manz, M G; Schroeder, T; Passegué, E (2016). Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nature Cell Biology, 18(6):607-618.

Sobottka, Bettina; Pestalozzi, Bernhard; Fink, Daniel; Moch, Holger; Varga, Zsuzsanna (2016). Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastases. OncoImmunology, 5(6):e1153208.

Schreiner, Florentine; Krayenbühl, Pierre-Alexandre; Goede, Jeroen S; Nowak, Albina (2016). CME: Zufallsbefund Hyperferritinämie. Praxis, 105:543-551.

Lipinski, Kamil Andrzej; Britschgi, Christian; Schrader, Karen; Christinat, Yann; Frischknecht, Lukas; Krek, Wilhelm (2016). Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1. OncoTarget, 7(20):29635-29647.

Schreiner, Florentine; Krayenbühl, P A; Nowak, A; Goede, Jeroen S (2016). Zufallsbefund Hyperferritinämie. Praxis, 105(10):543-551.

Wick, Wolfgang; Gorlia, Thierry; Bady, Pierre; Platten, Michael; van den Bent, Martin J; Taphoorn, Martin J B; Steuve, Jonathan; Brandes, Alba A; Hamou, Marie-France; Wick, Antje; Kosch, Markus; Weller, Michael; Stupp, Roger; Roth, Patrick; Golfinopoulos, Vassilis; Frenel, Jean-Sebastien; Campone, Mario; Ricard, Damien; Marosi, Christine; Villà, Salvador; Weyerbrock, Astrid; Hopkins, Kirsten; Homicsko, Krisztian; Lhermitte, Benoit; Pesce, Gianfranco Angelo; Hegi, Monika E (2016). Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082). Clinical Cancer Research, 22(19):4797-4806.

Dyshlovoy, S A; Venz, S; Hauschild, J; Tabakmakher, K M; Otte, K; Madanchi, R; Walther, R; Guzii, A G; Makarieva, T N; Shubina, L K; Fedorov, S N; Stonik, V A; Bokemeyer, C; Balabanov, S; Honecker, F; V Amsberg, G (2016). Anti-migratory activity of marine alkaloid monanchocidin A : proteomics-based discovery and confirmation. Proteomics, 16(10):1590-1603.

Pitter, K L; Tamagno, I; Alikhanyan, K; Hosni-Ahmed, A; Pattwell, S S; Donnola, S; Dai, C; Ozawa, T; Chang, M; Chan, T A; Beal, K; Bishop, A J; Barker, C A; Jones, T S; Hentschel, B; Gorlia, T; Schlegel, U; Stupp, R; Weller, M; Holland, E C; Hambardzumyan, D (2016). Corticosteroids compromise survival in glioblastoma. Brain, 139(Pt 5):1458-1471.

Fankhauser, Christian D; Bode, Peter K; Hermanns, Thomas; Sander, Sophia; Beyer, Joerg; Sulser, Tullio; Altevogt, Peter; Moch, Holger; Tischler, Verena (2016). L1-CAM is commonly expressed in testicular germ cell tumours. Journal of Clinical Pathology, 69(5):460-462.

Koeberle, D; Dufour, J-F; Demeter, G; Li, Q; Ribi, K; Samaras, P; Saletti, P; Roth, A D; Horber, D; Buehlmann, M; Wagner, A D; Montemurro, M; Lakatos, G; Feilchenfeldt, J; Peck-Radosavljevic, M; Rauch, D; Tschanz, B; Bodoky, G; Swiss Group for Clinical Cancer Research (SAKK) (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of Oncology, 27(5):856-861.

Beyer, J (2016). Therapie muskelinvasiver und metastasierter Tumoren. info@onkologie, 5:20-23.

Bacanovic, Sara; Stiller, Ruth; Pircher, Magdalena; Burger, Irene A; Huellner, Martin W (2016). Ovarian hyperstimulation and oocyte harvesting prior to systemic chemotherapy-a possible pitfall in 18F-FDG PET/CT staging of oncologic patients. Clinical Nuclear Medicine, 41(8):e394-e396.

Kresoja-Rakic, Jelena; Kapaklikaya, Esra; Ziltener, Gabriela; Dalcher, Damian; Santoro, Raffaella; Christensen, Brock C; Johnson, Kevin C; Schwaller, Beat; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2016). Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells. OncoTarget, 7(16):21272-21286.

Martini, Katharina; Meier, Andreas; Opitz, Isabelle; Weder, Walter; Veit-Haibach, Patrick; Stahel, Rolf A; Frauenfelder, Thomas (2016). Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma. Lung Cancer, 94:40-45.

Seifert, Heike; Fisher, Rosalie; Martin-Liberal, Juan; Edmonds, Kim; Hughes, Peta; Khabra, Komel; Gore, Martin; Larkin, James (2016). Prognostic markers and tumour growth kinetics in melanoma patients progressing on vemurafenib. Melanoma research, 26(2):138-144.

Theocharides, Alexandre P; Lundberg, Pontus; Lakkaraju, Asvin K K; Lysenko, Veronika; Myburgh, Renier; Aguzzi, Adriano; Skoda, Radek C; Manz, Markus G (2016). Homozygous Calreticulin mutations in patients with myelofibrosis lead to acquired myeloperoxidase deficiency. Blood, 127(25):3253-3259.

Gulden-Sala, W; Roth, P; Brown, M; Andratschke, N; Weller, M; Stupp, R (2016). Gliome – was ich wissen muss in zehn Fragen. Praxis, 105(6):330-337.

Cao, B; Zhang, Z; Grassinger, J; Williams, B; Heazlewood, C K; Churches, Q I; James, S A; Li, S; Papayannopoulou, T; Nilsson, S K (2016). Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist. Nature Communications, 7:11007.

Weidner, C I; Lin, Q; Birkhofer, C; Gerstenmaier, U; Kaifie, A; Kirschner, M; Bruns, H; Balabanov, S; Trummer, A; Stockklausner, C; Höchsmann, B; Schrezenmeier, H; Wlodarski, M; Panse, J; Brümmendorf, T H; Beier, F; Wagner, W (2016). DNA methylation in PRDM8 is indicative for dyskeratosis congenita. OncoTarget, 7(10):10765-10772.

Happold, C; Gorlia, T; Chinot, O; Gilbert, M R; Nabors, L B; Wick, W; Pugh, S L; Hegi, M; Cloughesy, T; Roth, P; Reardon, D A; Perry, J R; Mehta, M P; Stupp, R; Weller, M (2016). Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma. Journal of Clinical Oncology, 34(7):731-739.

Tamir, Adi; Sorrentino, Simona; Motahedeh, Sarah; Shai, Ela; Dubrovsky, Anna; Dahan, Idit; Eibauer, Matthias; Studt, Jan-Dirk; Sapra, K Tanuj; Varon, David; Medalia, Ohad (2016). The macromolecular architecture of platelet-derived microparticles. Journal of Structural Biology, 193(3):181-187.

Weller, Michael; Nabors, Louis Burt; Gorlia, Thierry; Leske, Henning; Rushing, Elisabeth; Bady, Pierre; Hicking, Christine; Perry, James; Hong, Yong-Kil; Roth, Patrick; Wick, Wolfgang; Goodman, Simon L; Hegi, Monika E; Picard, Martin; Moch, Holger; Straub, Josef; Stupp, Roger (2016). Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome. OncoTarget, 7(12):15018-15032.

Meerang, Mayura; Bérard, Karima; Felley-Bosco, Emanuela; Lauk, Olivia; Vrugt, Bart; Boss, Andreas; Kenkel, David; Broggini-Tenzer, Angela; Stahel, Rolf A; Arni, Stephan; Weder, Walter; Opitz, Isabelle (2016). Antagonizing the hedgehog pathway with vismodegib impairs malignant pleural mesothelioma growth in vivo by affecting stroma. Molecular Cancer Therapeutics, 15(5):1095-1105.

Feldman, Darren R; Lorch, Anja; Kramar, Andrew; Albany, Costantine; Einhorn, Lawrence H; Giannatempo, Patrizia; Necchi, Andrea; Flechon, Aude; Boyle, Helen; Chung, Peter; Huddart, Robert A; Bokemeyer, Carsten; Tryakin, Alexey; Sava, Teodoro; Winquist, Eric William; De Giorgi, Ugo; Aparicio, Jorge; Sweeney, Christopher J; Cohn Cedermark, Gabriella; Beyer, Jörg; Powles, Thomas (2016). Brain metastases in patients with germ cell tumors: prognostic factors and treatment options: an analysis from the global germ cell cancer group. Journal of Clinical Oncology, 34(4):345-351.

Riesterer, Oliver; Weder, Walter; Stahel, Rolf (2016). Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power? - Authors' reply. Lancet Oncology, 17(2):e44-e45.

Kröner, A; Aerts, E; Schanz, U; Spirig, R (2016). Mundspülung bei oraler Mukositis im Kontext der allogenen Stammzell-Transplantation: eine qualitative Studie. Pflege, 29(1):21-31.

Burger, Irene A; Casanova, Ruben; Steiger, Seraina; Husmann, Lars; Stolzmann, Paul; Huellner, Martin W; Curioni, Alessandra; Hillinger, Sven; Schmidtlein, Charles Ross; Soltermann, Alex (2016). FDG-PET/CT of non-small cell lung carcinoma under neo-adjuvant chemotherapy: background based adaptive volume metrics outperform TLG and MTV in predicting histopathological response. Journal of Nuclear Medicine, 57(6):849-854.

Boettcher, S; Manz, M G (2016). Sensing and translation of pathogen signals into demand-adapted myelopoiesis. Current Opinion in Hematology, 23(1):5-10.

Jantze, Annika; Haller, Christlieb; Delaloye, Raphaël (2016). CME: Neuroendokrine Tumoren. Praxis, 105(1):7-14.

Versluis, J; In't Hout, F E; Devillier, R; van Putten, W L; Manz, Markus G; Vekemans, M C; Legdeur, M C; Passweg, J R; Maertens, J; Kuball, J; Biemond, B J; Valk, P J; van der Reijden, B A; Meloni, G; Schouten, Harry C; Vellenga, Edo; Pabst, Thomas; Willemze, R; Löwenberg, B; Ossenkoppele, G; Baron, F; Huls, G; Cornelissen, J J (2016). Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio. Leukemia, 31(1):26-33.

Seifert, Heike; Hirata, Eishu; Gore, Martin; Khabra, Komel; Messiou, Christina; Larkin, James; Sahai, Erik (2016). Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases. Pigment Cell & Melanoma Research, 29(1):92-100.

Theocharides, A P; Rongvaux, A; Fritsch, K; Flavell, R A; Manz, M G (2016). Humanized hemato-lymphoid system mice. Haematologica, 101(1):5-19.

Curioni-Fontecedro, A; Pestalozzi, Bernhard C (2016). Immune checkpoint-Inhibitoren bei thorakalen Malignomen. Swiss Medical Forum:19-20.

Ziegler, P; Boettcher, S; Takizawa, H; Manz, M G; Brümmendorf, T H (2016). LPS-stimulated human bone marrow stroma cells support myeloid cell development and progenitor cell maintenance. Annals of Hematology, 95(2):173-178.

Mahgoub, Samir; Tsioptsias, Costas; Samaras, Petros (2016). Biodegradation and decolorization of melanoidin solutions by manganese peroxidase yeasts. Water Science and Technology, 73(10):2436-2445.

Tabernero, Josep; Vyas, Malvika; Giuliani, Rosa; Arnold, Dirk; Cardoso, Fatima; Casali, Paolo G; Cervantes, Andres; Eggermont, Alexander Mm; Eniu, Alexandru; Jassem, Jacek; Pentheroudakis, George; Peters, Solange; Rauh, Stefan; Zielinski, Christoph C; Stahel, Rolf A; Voest, Emile; Douillard, Jean-Yves; McGregor, Keith; Ciardiello, Fortunato (2016). Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers. ESMO Open, 1(6):e000142.

Morgan, Gilberto; Lambertini, Matteo; Kourie, Hampig Raphael; Amaral, Teresa; Argiles, Guillem; Banerjee, Susana; Cardone, Claudia; Corral, Jesus; De Mattos-Arruda, Letticia; Öztürk, Akif; Petrova, Mila; Poulsen, Laurids; Strijbos, Michiel; Tyulyandina, Alexandra; Vidra, Radu; Califano, Raffaele; de Azambuja, Evandro; Garrido Lopez, Pilar; Guarneri, Valentina; Reck, Martin; Moiseyenko, Vladimir; Martinelli, Erika; Douillard, Jean-Yves; Stahel, Rolf; Voest, Emile; Arnold, Dirk; Cardoso, Fatima; Casali, Paolo; Cervantes, Andrés; Eggermont, Alexander M M; et al (2016). Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open, 1:e000107.

Razafinjatovo, Caroline; Bihr, Svenja; Mischo, Axel; Vogl, Ursula; Schmidinger, Manuela; Moch, Holger; Schraml, Peter (2016). Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance. BMC Cancer, 16:638.

Dittrich, Christian; Kosty, Michael; Jezdic, Svetlana; Pyle, Doug; Berardi, Rossana; Bergh, Jonas; El-Saghir, Nagi; Lotz, Jean-Pierre; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta; Awada, Ahmad; Banerjee, Susana; Bhatia, Smita; Bogaerts, Jan; Buckner, Jan; Cardoso, Fatima; Casali, Paolo; Chu, Edward; Close, Julia Lee; Coiffier, Bertrand; Connolly, Roisin; Coupland, Sarah; De Petris, Luigi; De Santis, Maria; de Vries, Elisabeth G E; Dizon, Don S; Duff, Jennifer; Duska, Linda R; Eniu, Alexandru; et al (2016). ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open, 1(5):e000097.

Saito, Y; Ellegast, J M; Manz, M G (2016). Generation of humanized mice for analysis of human dendritic cells. In: Segura, Elodie; Onai, Nobuyuki. Dendritic Cell Protocols. New York: Springer, 309-320.

Body, Jean-Jacques; Pereira, João; Sleeboom, Harm; Maniadakis, Nikos; Terpos, Evangelos; Acklin, Yves Pascal; Finek, Jindrich; Gunther, Oliver; Hechmati, Guy; Mossman, Tony; Costa, Luis; Rogowski, Wojciech; Nahi, Hareth; von Moos, Roger (2016). Health resource utilization associated with skeletal-related events: results from a retrospective European study. European Journal of Health Economics, 17(6):711-721.

Bangrad, C Hämatologie und Onkologie : fallorientierte Darstellung - rationale Diagnostik und Therapie. Edited by: Kreuzer, Karl-Anton; Beyer, Jörg (2016). Stuttgart: Thieme Verlag.

Madanchi, Mehdi; Zeitz, Jonas; Barthel, Christiane; Samaras, Panagiotis; Scharl, Sylvie; Sulz, Michael C; Biedermann, Luc; Frei, Pascal; Vavricka, Stephan R; Rogler, Gerhard; Scharl, Michael (2016). Malignancies in patients with inflammatory bowel disease: a single-centre experience. Digestion, 94(1):1-8.

Stanek, Nadine; Bauerfeind, Peter; Herzog, Guido; Heinrich, Henriette; Sauter, Matthias; Lenggenhager, Daniela; Reiner, Cäcilia; Manz, Markus G; Goede, Jeroen S; Misselwitz, Benjamin (2016). Marginal zone lymphoma complicated by protein losing enteropathy. Case Reports in Hematology, 2016:9351408.

Winder, Thomas. Molecular based oncology in colorectal- and gastric cancer. 2016, University of Zurich, Faculty of Medicine.

von Moos, Roger; Body, Jean-Jacques; Egerdie, Blair; Stopeck, Alison; Brown, Janet; Fallowfield, Lesley; Patrick, Donald L; Cleeland, Charles; Damyanov, Danail; Palazzo, Felipe Salvador; Marx, Gavin; Zhou, Ying; Braun, Ada; Balakumaran, Arun; Qian, Yi (2016). Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive Care in Cancer, 24(3):1327-1337.

Stieb, Sonja; Riesterer, Oliver; Brüssow, Cornelia; Pestalozzi, Bernhard C; Guckenberger, Matthias; Weiler, Stefan (2016). Radiation recall dermatitis induced by sorafenib : A case study and review of the literature. Strahlentherapie und Onkologie, 195(5):342-348.

Kostron, Arthur; Friess, Martina; Crameri, Ornella; Inci, Ilhan; Schneiter, Didier; Hillinger, Sven; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2016). Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma†. European Journal of Cardio-Thoracic Surgery, 49(5):1516-1523.

Klein, H J; Schanz, U; Hivelin, M; Waldner, M; Koljonen, V; Guggenheim, M; Giovanoli, P; Gorantla, V S; Fehr, T; Plock, J A (2016). Sensitization and desensitization of burn patients as potential candidates for vascularized composite allotransplantation. Burns, 42(2):246-257.

Kiessling, Michael K; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis; Lang, Silvia; Scharl, Michael; Aguzzi, Adriano; Oldrige, Derek A; Maris, John M; Rogler, Gerhard (2016). Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma. PLoS ONE, 11(1):e0147682.

Nombela-Arrieta, César; Isringhausen, Stephan (2016). The Role of the Bone Marrow Stromal Compartment in the Hematopoietic Response to Microbial Infections. Frontiers in Immunology, 7:689.

Strasser, F; Blum, D; von Moos, R; Cathomas, R; Ribi, K; Aebi, S; Betticher, D; Hayoz, S; Klingbiel, D; Brauchli, P; Haefner, M; Mauri, S; Kaasa, S; Koeberle, D (2016). The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Annals of Oncology, 27(2):324-332.

Driessen, Christoph; Kraus, Marianne; Joerger, Markus; Rosing, Hilde; Bader, Jürgen; Hitz, Felicitas; Berset, Catherine; Xyrafas, Alexandros; Hawle, Hanne; Berthod, Gregoire; Overkleeft, Hermann S; Sessa, Cristiana; Huitema, Alwin; Pabst, Thomas; von Moos, Roger; Hess, Dagmar; Mey, Ulrich J M (2016). Treatment with the HIV protease inhibitor Nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08). Haematologica, 101(3):346-355.

Beyer, J (2016). Urogenitale Tumoren („non-prostate“). Leading Opinions, 4:56-58.

Volk, Viktoria; Cathomas, Richard; Mark, Michael; von Moos, Roger; Klingbiel, Dirk; Brossart, Peter; Mey, Ulrich (2016). Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experience. Supportive Care in Cancer, 24(5):2119-2128.

Hawkey, Christopher J; Allez, Matthieu; Clark, Miranda M; Labopin, Myriam; Lindsay, James O; Ricart, Elena; Rogler, Gerhard; Rovira, Montserrat; Satsangi, Jack; Danese, Silvio; Russell, Nigel; Gribben, John; Johnson, Peter; Larghero, Jerome; Thieblemont, Catherine; Ardizzone, Sandro; Dierickx, Daan; Ibatici, Adalberto; Littlewood, Timothy; Onida, Francesco; Schanz, Urs; Vermeire, Severine; Colombel, Jean-Frederic; Jouet, Jean-Paul; Clark, Elizabeth; Saccardi, Riccardo; Tyndall, Alan; Travis, Simon; Farge, Dominique (2015). Autologous hematopoetic stem cell transplantation for refractory crohn disease: a randomized clinical trial. JAMA : the Journal of the American Medical Association, 314(23):2524-2534.

Stupp, Roger; Taillibert, Sophie; Kanner, Andrew A; Kesari, Santosh; Steinberg, David M; Toms, Steven A; Taylor, Lynne P; Lieberman, Frank; Silvani, Antonio; Fink, Karen L; Barnett, Gene H; Zhu, Jay-Jiguang; Henson, John W; Engelhard, Herbert H; Chen, Thomas C; Tran, David D; Sroubek, Jan; Tran, Nam D; Hottinger, Andreas F; Landolfi, Joseph; Desai, Rajiv; Caroli, Manuela; Kew, Yvonne; Honnorat, Jerome; Idbaih, Ahmed; Kirson, Eilon D; Weinberg, Uri; Palti, Yoram; Hegi, Monika E; Ram, Zvi (2015). Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA : the Journal of the American Medical Association, 314(23):2535-2543.

Shakhova, Olga; Sommer, Lukas (2015). In vitro derivation of melanocytes from embryonic neural crest stem cells. Methods in Molecular Biology:1-8.

Kiessling, Michael K; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis; Atrott, Kirstin; Cosin-Roger, Jesus; Lang, Silvia; Scharl, Michael; Rogler, Gerhard (2015). Mutant HRAS as novel target for MEK and mTOR inhibitors. OncoTarget, 6(39):42183-42196.

Brand, B; Dunn, S; Kulkarni, R (2015). Challenges in the management of haemophilia on transition from adolescence to adulthood. European Journal of Haematology, 95(S81):30-35.

Gemuenden, C; Benz, R; Senn, O; Goede, J S; Manz, M G; Gerber, B (2015). Efficacy of azacitidine in de novo and relapsed acute myeloid leukemia: a retrospective comparative study. Clinical Lymphoma, Myeloma & Leukemia:811-815.

Stahel, Rolf A; Riesterer, Oliver; Xyrafas, Alexandros; Opitz, Isabelle; Beyeler, Michael; Ochsenbein, Adrian; Früh, Martin; Cathomas, Richard; Nackaerts, Kristiaan; Peters, Solange; Mamot, Christoph; Zippelius, Alfred; Mordasini, Carlo; Caspar, Clemens B; Eckhardt, Katrin; Schmid, Ralph A; Aebersold, Daniel M; Gautschi, Oliver; Nagel, Wolfgang; Töpfer, Michael; Krayenbuehl, Jerome; Ribi, Karin; Ciernik, Llja F; Weder, Walter (2015). Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. Lancet Oncology, 16(16):1651-1658.

Body, J; Henry, D; von Moos, R; Rider, A; De Courcy, J; Murray, G; Bhowmik, D; Gatta, F; Arellano, J; Hechmati, G; Qian, Y (2015). Bone pain and bone targeting agent (Bta) treatment pattern in patients with bone metastases (Bms) from prostate cancer (Pc) in real world setting in Europe. Value in Health, 18(7):A493.

Seifert, Heike; Georgiou, Alexandros; Alexander, Helen; McLachlan, Jennifer; Bodla, Shankar; Kaye, Stan; Barton, Desmond; Nobbenhuis, Marielle; Gore, Martin; Banerjee, Susana (2015). Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC). Gynecologic Oncology, 139(2):216-220.

Hegi, Monika E; Stupp, Roger (2015). Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter - still a dilemma? Neuro-Oncology, 17(11):1425-1427.

Moretti, D; Goede, J S; Zeder, C; Jiskra, M; Chatzinakou, V; Tjalsma, H; Melse-Boonstra, A; Brittenham, G; Swinkels, D W; Zimmermann, M B (2015). Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood, 126(17):1981-1989.

Werner, B; Beier, F; Hummel, S; Balabanov, S; Lassay, L; Orlikowsky, T; Dingli, D; Brümmendorf, T H; Traulsen, A (2015). Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions. eLife, 4:e08687.

Fuchs, I; Gerber, B; Samaras, P (2015). Monoklonale Gammopathie in der hausärztlichen Praxis: diagnostische Abklärung und Therapie des Plasmazell-Myeloms. Praxis, 104(21):1141-1150.

Gautschi, Oliver; Milia, Julie; Cabarrou, Bastien; Bluthgen, Marie-Virginia; Besse, Benjamin; Smit, Egbert F; Wolf, Juergen; Peters, Solange; Früh, Martin; Koeberle, Dieter; Oulkhouir, Youssouf; Schuler, Martin; Curioni-Fontecedro, Alessandra; Huret, Benjamin; Kerjouan, Mallorie; Michels, Sebastian; Pall, Georg; Rothschild, Sacha; Schmid-Bindert, Gerald; Scheffler, Matthias; Veillon, Rémi; Wannesson, Luciano; Diebold, Joachim; Zalcman, Gérard; Filleron, Thomas; Mazières, Julien (2015). Targeted therapy for patients with BRAF-mutant lung cancer: results from the european EURAF cohort. Journal of Thoracic Oncology, 10(10):1451-1457.

Gautschi, Oliver; Mach, Nicholas; Rothschild, Sacha I; Li, Qiyu; Stahel, Rolf A; Zippelius, Alfred; Cathomas, Richard; Früh, Martin; Betticher, Daniel C; Peters, Solange; Rauch, Daniel; Feilchenfeldt, Jonas; Bubendorf, Lukas; Savic, Spasenija; Jaggi, Rolf; Leibundgut, Elisabeth Oppliger; Largiadèr, Carlo; Brutsche, Martin; Pilop, Christiane; Stalder, Lukas; Pless, Miklos; Ochsenbein, Adrian F (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical Lung Cancer, 16(5):358-365.

Passweg, J R; Schanz, U; Chalandon, Y; Güngör, T; Baldomero, H; Heim, D; Nair, G; Medinger, M; Masouridi-Levrat, S; de Faveri, G N; Tiercy, J-M (2015). High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities. Bone Marrow Transplantation, 50(9):1201-1205.

Tschan, Mario P; Federzoni, Elena A; Haimovici, Aladin; Britschgi, Christian; Moser, Bettina A; Jin, Jing; Reddy, Venkateshwar A; Sheeter, Dennis A; Fischer, Kimberlee M; Sun, Peiqing; Torbett, Bruce E (2015). Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation. BBA - Biochimica et Biophysica Acta, 1849(9):1198-1208.

Pentheroudakis, G; Cardoso, F; Arnold, D; Sessa, C; Peters, S; Horwich, A; Pavlidis, N; Stahel, R; Cervantes, A (2015). The ESMO guideline strategy: an identity statement and reflections on improvement. Annals of Oncology, 26 Suppl:v1-v7.

Opitz, Isabelle; Friess, Martina; Kestenholz, Peter; Schneiter, Didier; Frauenfelder, Thomas; Nguyen-Kim, Dan Linh; Seifert, Burkhardt; Hoda, Mir Alireza; Klepetko, Walter; Stahel, Rolf A; Weder, Walter (2015). A new prognostic score supporting treatment allocation for multimodality therapy for malignant pleural mesothelioma- A review of 12 years' experience. Journal of Thoracic Oncology, 10(11):1634-1641.

Filatenkow, A; Baker, J; Mueller, A M; Kenkel, J; Ahn, G; Dutt, S; Zhang, N; Kohrt, H; Jensen, K; Deijbakhsh-Jones, S; Shizuru, J A; Negrin, R N; Engleman, E G; Strober, S (2015). Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions. Clinical Cancer Research, 21(16):3727-3739.

Mehra, Tarun; Seifert, Burkhardt; Bravo-Reiter, Silvina; Wanner, Guido; Dutkowski, Philipp; Holubec, Tomas; Moos, Rudolf M; Volbracht, Jörk; Manz, Markus G; Spahn, Donat R (2015). Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. Transfusion, 55(12):2807-2815.

Pless, Miklos; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A; Weder, Walter; Thierstein, Sandra; Gerard, Marie-Aline; Xyrafas, Alexandros; Früh, Martin; Cathomas, Richard; Zippelius, Alfred; Roth, Arnaud; Bijelovic, Milorad; Ochsenbein, Adrian; Meier, Urs R; Mamot, Christoph; Rauch, Daniel; Gautschi, Oliver; Betticher, Daniel C; Mirimanoff, René-Olivier; Peters, Solange (2015). Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet, 386(9998):1049-1056.

Eberhardt, W E E; De Ruysscher, D; Weder, W; Le Péchoux, C; De Leyn, P; Hoffmann, H; Westeel, V; Stahel, R; Felip, E; Peters, S (2015). 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Annals of Oncology, 26(8):1573-1588.

Stahel, R A; Weder, W; Felley-Bosco, E; Petrausch, U; Curioni-Fontecedro, A; Schmitt-Opitz, I; Peters, S (2015). Searching for targets for the systemic therapy of mesothelioma. Annals of Oncology, 26(8):1649-1660.

Fankhauser, C D; Curioni-Fontecedro, A; Allmann, V; Beyer, J; Tischler, V; Sulser, T; Moch, H; Bode, P K (2015). Frequent PD-L1 expression in testicular germ cell tumors. British Journal of Cancer, 113(3):411-413.

Dyshlovoy, S A; Hauschild, J; Amann, K; Tabakmakher, K M; Venz, S; Walther, R; Guzii, A G; Makarieva, T N; Shubina, L K; Fedorov, S N; Stonik, V A; Bokemeyer, C; Balabanov, S; Honecker, F; von Amsberg, G (2015). Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization. OncoTarget, 6(19):17328-17341.

Mager, L F; Riether, C; Schürch, C M; Banz, Y; Wasmer, M H; Stuber, R; Theocharides, A P; Li, X; Xia, Y; Saito, H; Nakae, S; Baerlocher, G M; Manz, M G; McCoy, K D; Macpherson, A J; Ochsenbein, AF; Beutler, B; Krebs, P (2015). IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. Journal of Clinical Investigation, 125(7):2579-2591.

Myburgh, Renier; Ivic, Sandra; Pepper, Michael S; Gers-Huber, Gustavo; Li, Duo; Audigé, Annette; Rochat, Mary-Aude; Jaquet, Vincent; Regenass, Stephan; Manz, Markus G; Salmon, Patrick; Krause, Karl-Heinz; Speck, Roberto F (2015). Lentivector knockdown of CCR5 in hematopoietic stem and progenitor cells confers functional and persistent HIV-1 resistance in humanized mice. Journal of Virology, 89(13):6761-6772.

Diel, Ingo J; Body, Jean-Jacques; Stopeck, Alison T; Vadhan-Raj, Saroj; Spencer, Andrew; Steger, Günther; von Moos, Roger; Goldwasser, François; Feng, Amy; Braun, Ada (2015). The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. European Journal of Cancer, 51(11):1467-1475.

Schweizer, M; Goede, J S; Briner, V (2015). Patients with an extraordinarily elevated serum ferritin: think of haemophagocytic lymphohistiocytosis. Swiss Medical Weekly, 145:w14152.

Pallmann, Nora; Braig, Melanie; Sievert, Henning; Preukschas, Michael; Hermans-Borgmeyer, Irm; Schweizer, Michaela; Nagel, Claus Henning; Neumann, Melanie; Wild, Peter; Haralambieva, Eugenia; Hagel, Christian; Bokemeyer, Carsten; Hauber, Joachim; Balabanov, Stefan (2015). Biological relevance and therapeutic potential of the hypusine modification system. Journal of Biological Chemistry, 290(30):18343-18360.

Gerber, Bernhard (2015). Plasmazellmyelom: gute Zusammenarbeit aller Beteiligten hilft. Praxis, 104(10):489-490.

Chowdary, P; Lethagen, S; Friedrich, U; Brand, B; Hay, C; Abdul Karim, F; Klamroth, R; Knoebl, P; Laffan, M; Mahlangu, J; Miesbach, W; Daalsgaard Nielsen, J; Martin-Salces, M; Angchaisuksiri, P (2015). Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. Journal of Thrombosis and Haemostasis, 13(5):743-754.

Ummanni, R; Duscharla, D; Barett, C; Venz, S; Schlomm, T; Heinzer, H; Walther, R; Bokemeyer, C; Brümmendorf, T H; Murthy, P V; Balabanov, S (2015). Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers. Journal of Proteomics, 119:218-229.

Fuchs, Ivo; Petrausch, Ulf; Pangalu, Athina; Schäfer, Niklaus; Samaras, Panagiotis (2015). CME. Diffuses, grosszelliges B-Zell-Lymphom (DLBCL). Praxis, 104(9):441-449.

Limani, Perparim; Samaras, Panagiotis; Lesurtel, Mickael; Graf, Rolf; DeOliveira, Michelle L; Petrowsky, Henrik; Clavien, Pierre-Alain (2015). Pancreatic cancer- a curable disease. Praxis, 104(9):453-60.

Dhedin, N; Huynh, A; Maury, S; Tabrizi, R; Beldjord, K; Asnafi, V; Thomas, X; Chevallier, P; Nguyen, S; Coiteux, V; Bourhis, J H; Hichri, Y; Escoffre-Barbe, M; Reman, O; Graux, C; Chalandon, Y; Blaise, D; Schanz, U; Lhéritier, V; Domret, H; Ifrah, N (2015). Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood, 125(16):2486-2496.

Blum, Walter; Pecze, László; Felley-Bosco, Emanuela; Worthmüller-Rodriguez, Janine; Wu, Licun; Vrugt, Bart; de Perrot, Marc; Schwaller, Beat (2015). Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line. In vitro cellular & developmental biology. Animal, 51(7):714-721.

Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollar, A; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V; Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26(4):709-714.

Patrick, Donald L; Cleeland, Charles S; von Moos, Roger; Fallowfield, Lesley; Wei, Rachel; Öhrling, Katarina; Qian, Yi (2015). Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents. Supportive Care in Cancer, 23(4):1157-1168.

Sorrentino, Simona; Studt, Jan-Dirk; Medalia, Ohad; Tanuj Sapra, K (2015). Roll, adhere, spread and contract: structural mechanics of platelet function. European Journal of Cell Biology, 94(3-4):129-138.

Hanggi, Pascal; Telezhkin, Vsevolod; Kemp, Paul J; Schmugge, Markus; Gassmann, Max; Goede, Jeroen S; Speer, Oliver; Bogdanova, Anna (2015). Functional plasticity of the N-methyl-D-aspartate receptor in differentiating human erythroid precursor cells. American journal of Physiology. Cell physiology, 308(12):C993-C1007.

Ulrich, A; Weiler, S; Weller, M; Rordorf, T; Tarnutzer, A A (2015). Cetuximab induced aseptic meningitis. Journal of Clinical Neuroscience, 22(6):1061-1063.

Reinhart, Walter H; Piety, Nathaniel Z; Deuel, Jeremy W; Makhro, Asya; Schulzki, Thomas; Bogdanov, Nikolay; Goede, Jeroen S; Bogdanova, Anna; Abidi, Rajaa; Shevkoplyas, Sergey S (2015). Washing stored red blood cells in an albumin solution improves their morphologic and hemorheologic properties. Transfusion, 55(8):1872-1881.

Reinhart, W H; Piety, N Z; Goede, J S; Shevkoplyas, S S (2015). Effect of osmolality on erythrocyte rheology and perfusion of an artificial microvascular network. Microvascular Research, 98:102-107.

Frischknecht, Lukas; Meerang, Mayura; Soltermann, Alex; Stahel, Rolf; Moch, Holger; Seifert, Burkhardt; Weder, Walter; Opitz, Isabelle (2015). Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery. Journal of Thoracic and Cardiovascular Surgery, 149(6):1539-1547.e1.

Berres, M L; Lim, K P; Peters, T; Price, J; Takizawa, H; Salmon, H; Idoyaga, J; Ruzo, A; Lupo, P J; Hicks, M J; Shih, A; Simko, S J; Abhyankar, H; Chakraborty, R; Leboeuf, M; Beltrao, M; Lira, S A; Heym, K M; Clausen, B E; Bigley, V; Collin, M; Manz, M G; McClain, K; Merad, M; Allen, C E (2015). Erratum for BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. Journal of Experimental Medicine, 212(2):281.

Weller, Michael; Tabatabai, G; Kästner, B; Felsberg, J; Steinbach, J P; Wick, A; Schnell, O; Hau, P; Herrlinger, U; Sabel, M C; Wirsching, H G; Ketter, R; Bähr, O; Platten, M; Tonn, J C; Schlegel, U; Marosi, C; Goldbrunner, R; Stupp, R; Homicsko, K; Pichler, J; Nikkhah, G; Meixensberger, J; Vajkoczy, P; Kollias, S; Hüsing, J; Reifenberger, G; Wick, W (2015). MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial. Clinical Cancer Research, 21(9):2057-2064.

Siebenhüner, A; Winder, T; Petrowsky, Henrik; Clavien, Pierre-Alain; Pestalozzi, Bernhard C (2015). Therapie des metastasierten kolorektalen Karzinoms am Beispiel von metachronen Lebermetastasen. CME, 104(2):67-79.

Zingg, Daniel; Debbache, Julien; Schaefer, Simon M; Tuncer, Eylul; Frommel, Sandra C; Cheng, Phil; Arenas-Ramirez, Natalia; Haeusel, Jessica; Zhang, Yudong; Bonalli, Mario; McCabe, Michael T; Creasy, Caretha L; Levesque, Mitchell P; Boyman, Onur; Santoro, Raffaella; Shakhova, Olga; Dummer, Reinhard; Sommer, Lukas (2015). The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nature Communications, 6:6051.

Kwak, H J; Liu, P; Xu, Y; Park, S Y; Nombela Arrieta, C; Mondal, S; Sun, Y; Zhu, H; Chai, L; Silberstein, L E; Cheng, T; Luo, H R (2015). Myeloid cell-derived reactive oxygen species externally regulate the proliferation of myeloid progenitors in emergency granulopoiesis. Immunity:159-71.

Hofer, Silvia; Mengele, Karin; Schmitt, Manfred; Pestalozzi, Bernhard; Aebi, Stefan (2015). Complement activation and rituximab distribution in CNS NHL: letter. Clinical Cancer Research, 21(2):490.

Siebenhüner, Alexander; Winder, Thomas; Petrowsky, Henrik; Clavien, Pierre-Alain; Pestalozzi, Bernhard (2015). Therapy of metastatic colorectal carcinoma exemplified in metachronous liver metastases. Praxis, 104(2):67-79.

Mehra, Tarun; Ikenberg, Kristian; Moos, Rudolf Maria; Benz, Rudolf; Nair, Gayathri; Schanz, Urs; Haralambieva, Eugenia; Hoetzenecker, Wolfram; Dummer, Reinhard; French, Lars Einar; Guenova, Emmanuella; Cozzio, Antonio (2015). Brentuximab as a treatment for CD30+ Mycosis Fungoides and Sézary Syndrome. JAMA Dermatology, 151(1):73-77.

Petrausch, U; Pircher, M; Reding, Daniel; Ballmer-Weber, B K; Pestalozzi, Bernhard C (2015). Deactivation to antineoplastic agents. Schweizer Krebsbulletin, 2015(1):42-44.

Theocharides, A P; Dobson, S M; Laurenti, E; Notta, F; Voisin, V; Cheng, P Y; Yuan, J S; Guidos, C J; Minden, M D; Mullighan, C G; Torlakovic, E; Dick, J E (2015). Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts. Leukemia, 29(1):177-187.

Weller, Michael; Wick, Wolfgang; Aldape, Ken; Brada, Michael; Berger, Mitchell; Pfister, Stefan M; Nishikawa, Ryo; Rosenthal, Mark; Wen, Patrick Y; Stupp, Roger; Reifenberger, Guido (2015). Glioma. Nature Reviews. Disease Primers, (2015):15017.

Santagostino, E; Lentz, SR; Misgav, M; Brand, B; Chowdary, P; Savic, A; Kilinc, Y; Amit, Y; Amendola, A; Solimeno, LP; Saugstrup, T; Matytsina, I (2015). Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials. Haemophilia, 21(1):34-40.

Matter-Walstra, K; Braun, R; Kolb, C; Ademi, Z; Dummer, R; Pestalozzi, B C; Schwenkglenks, M (2015). A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting. British Journal of Dermatology, 173(6):1462-1470.

Bausch-Fluck, Damaris; Hofmann, Andreas; Bock, Thomas; Frei, Andreas P; Cerciello, Ferdinando; Jacobs, Andrea; Moest, Hansjoerg; Omasits, Ulrich; Gundry, Rebekah L; Yoon, Charles; Schiess, Ralph; Schmidt, Alexander; Mirkowska, Paulina; Härtlová, Anetta; Van Eyk, Jennifer E; Bourquin, Jean-Pierre; Aebersold, Ruedi; Boheler, Kenneth R; Zandstra, Peter; Wollscheid, Bernd (2015). A mass spectrometric-derived cell surface protein atlas. PLoS ONE, 10(3):e0121314.

Rechsteiner, M; Wild, P; Kiessling, M K; Bohnert, A; Zhong, Q; Stahel, R A; Moch, H; Curioni-Fontecedro, A (2015). A novel germline mutation of PDGFR-β might be associated with clinical response of colorectal cancer to regorafenib. Annals of Oncology, 26(1):246-248.

Purohit, Bela; Winder, Thomas; Maggio, Ewerton Marques; Kollias, Spyros S (2015). Aggressive primary olfactory neuroblastoma of the sphenoclival region: A case report and literature review. The Laryngoscope, 125(4):822-825.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri; Szucs, Thomas; Pestalozzi, Bernhard C; Schwenkglenks, Matthias (2015). Cancer-related therapies at the end of life in hospitalized cancer patients from four swiss cantons: SAKK 89/09. Oncology, 88(1):18-27.

Sandrock-Lang, K; Oldenburg, J; Wiegering, V; Halimeh, S; Santoso, S; Kurnik, K; Fischer, L; Tsakiris, D A; Sigl-Kraetzig, M; Brand, B; Bührlen, M; Kraetzer, K; Deeg, N; Hund, M; Busse, E; Kahle, A; Zieger, B (2015). Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations. Thrombosis and Haemostasis, 113(4):782-791.

Curioni-Fontecedro, Alessandra; Martin, Vittoria; Vogetseder, Alexander; Knuth, Alexander; Moch, Holger; Soldini, Davide; Tinguely, Marianne (2015). Chromosomal aberrations of cancer-testis antigens in myeloma patients. Hematological oncology, 33(3):159-163.

Kurscheid, S; Bady, P; Sciuscio, D; Samarzija, I; Shay, T; Vassallo, I; Criekinge, W V; Daniel, R T; van den Bent, M J; Marosi, C; Weller, M; Mason, W P; Domany, E; Stupp, R; Delorenzi, M; Hegi, M E (2015). Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma. Genome Biology, 16(1):16.

Cornelissen, J J; Versluis, J; Passweg, J R; van Putten, W L; Manz, M G; Maertens, J; Beverloo, H B; Valk, P J; van Marwijk, Kooy M; Wijermans, P W; Schaafsma, M R; Biemond, B J; Vekemans, M C; Breems, D A; Verdonck, L F; Fey, M F; Jongen-Lavrencic, M; Janssen, J J; Huls, G; Kuball, J; Pabst, T; Graux, C; Schouten, H C; Gratwohl, A; Vellenga, E; Ossenkoppele, G; Löwenberg, B (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5):1041-1050.

Kumar, Karthiga Santhana; Pillong, Max; Kunze, Jens; Burghardt, Isabel; Weller, Michael; Grotzer, Michael A; Schneider, Gisbert; Baumgartner, Martin (2015). Computer-assisted quantification of motile and invasive capabilities of cancer cells. Scientific Reports, 5:15338.

Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Duchosal, Michel A; Heim, Dominik; Hess, Urs; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Taverna, Christian; Zander, Thilo; Renner, Christoph (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss Medical Weekly, 145:w14100.

Samaras, Panagiotis; Pfrommer, Sarah; Seifert, Burkhardt; Petrausch, Ulf; Mischo, Axel; Schmidt, Adrian; Schanz, Urs; Nair, Gayathri; Bargetzi, Mario; Taverna, Christian; Stupp, Roger; Stenner-Liewen, Frank; Renner, Christoph (2015). Efficacy of vinorelbine plus G-CSF for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma. Biology of Blood and Marrow Transplantation, 21(1):74-80.

Thies, Svenja; Friess, Martina; Frischknecht, Lukas; Korol, Dimitri; Felley-Bosco, Emanuela; Stahel, Rolf; Vrugt, Bart; Weder, Walter; Opitz, Isabelle; Soltermann, Alex (2015). Expression of the stem cell factor nestin in malignant pleural mesothelioma is associated with poor prognosis. PLoS ONE, 10(9):e0139312.

Oing, Christoph; Lorch, Anja; Bokemeyer, Carsten; Honecker, Friedemann; Beyer, Jörg; Berger, Lars Arne; Oechsle, Karin (2015). First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database. Journal of Cancer Research and Clinical Oncology, 141(5):923-931.

De Meyer, Tim; Bady, Pierre; Trooskens, Geert; Kurscheid, Sebastian; Bloch, Jocelyne; Kros, Johan M; Hainfellner, Johannes A; Stupp, Roger; Delorenzi, Mauro; Hegi, Monika E; Van Criekinge, Wim (2015). Genome-wide DNA methylation detection by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison. Scientific Reports, 5:15375.

Pircher, M; Winder, T; Pestalozzi, B C; Petrausch, U (2015). Immuntherapien – eine neue tragende Säule der Onkologie. PharmaJournal, 20:5-11.

Echeverry, N; Ziltener, G; Barbone, D; Weder, W; Stahel, R A; Broaddus, V C; Felley-Bosco, E (2015). Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors. Cell Death and Disease, 6:e1757.

Curioni-Fontecedro, A; Pitocco, R; Schoenewolf, N L; Holzmann, D; Soldini, D; Dummer, R; Calvieri, S; Moch, H; Mihic-Probst, D; Fitsche, A (2015). Intratumoral heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 expression in mucosal melanoma. BioMed Research International, 2015:432479.

Cheng, Phil F; Shakhova, Olga; Widmer, Daniel S; Eichhoff, Ossia M; Zingg, Daniel; Frommel, Sandra C; Belloni, Benedetta; Raaijmakers, Marieke Ig; Goldinger, Simone M; Santoro, Raffaella; Hemmi, Silvio; Sommer, Lukas; Dummer, Reinhard; Levesque, Mitchell P (2015). Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Genome Biology, 16:42.

Moch, Holger; Montironi, Rodolfo; Lopez-Beltran, Antonio; Cheng, Liang; Mischo, Axel (2015). Oncotargets in different renal cancer subtypes. Current Drug Targets, 16(2):125-135.

Stahel, R; Bogaerts, J; Ciardiello, F; de Ruysscher, D; Dubsky, P; Ducreux, M; Finn, S; Laurent-Puig, P; Peters, S; Piccart, M; Smit, E; Sotiriou, C; Tejpar, S; Van Cutsem, E; Tabernero, J (2015). Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development. Cancer Treatment Reviews, 41(2):129-135.

Blum, Walter; Pecze, László; Felley-Bosco, Emanuela; Schwaller, Beat (2015). Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration. Respiratory Research, 16:153.

Thalhammer, Verena; Lopez-Garcia, Laura A; Herrero Martín, David; Hecker, Regina; Laubscher, Dominik; Gierisch, Maria E; Wachtel, Marco; Bode, Peter; Nanni, Paolo; Blank, Bernd; Koscielniak, Ewa; Schäfer, Beat W (2015). PLK1 phosphorylates PAX3-FOXO1 the inhibition of which triggers regression of alveolar rhabdomyosarcoma. Cancer Research, 75(1):98-110.

Rusch, Andreas; Ziltener, Gabriela; Nackaerts, Kristiaan; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2015). Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases. Lung Cancer, 87(1):77-79.

Henzi, N; Vrugt, B; Schneiter, D; Studt, J D; Huber, L C (2015). Pulmonales Panoptikum nach Lungenbiopsie. Swiss Medical Forum:958-961.

Cathomas, Richard; Rothermundt, Christian; Bode, Beata; Fuchs, Bruno; von Moos, Roger; Schwitter, Michael (2015). RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward? Oncology, 88(4):257-260.

Niegisch, G; Retz, M; Thalgott, M; Balabanov, S; Honecker, F; Ohlmann, C H; Stöckle, M; Bögemann, M; Vom Dorp, F; Gschwend, J; Hartmann, A; Ohmann, C; Albers, P (2015). Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09). Oncology, 89(2):70-78.

Pircher, Magdalena; Schirrmann, Thomas; Petrausch, Ulf (2015). T Cell Engineering. In: Michielin, O; Coukos, G. Immuno-Oncology. Basel: Karger, 110-135.

Frauenfelder, Thomas; Kestenholz, Peter; Hunziker, Roger; Nguyen, Thi Dan Linh; Fries, Martina; Veit-Haibach, Patrick; Husmann, Lars; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2015). Use of Computed Tomography and Positron Emission Tomography/Computed Tomography for Staging of Local Extent in Patients With Malignant Pleural Mesothelioma. Journal of Computer Assisted Tomography, 39(2):160-165.

Stupp, R; Picard, M; Weller, M (2014). Does cilengitide deserve another chance?-Authors' reply. Lancet Oncology, 15(13):e585-e586.

Kerlin, B; Brand, B; Inbal, A; Halimeh, S; Nugent, D; Lundblad, M; Tehranchi, R (2014). Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency. Journal of Thrombosis and Haemostasis, 12(12):2038-2043.

Honecker, F; Rohlfing, T; Harder, S; Braig, M; Gillis, A J; Glaesener, S; Barett, C; Bokemeyer, C; Buck, F; Brümmendorf, T H; Looijenga, L H; Balabanov, S (2014). Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines. Journal of Proteomics, 96:300-313.

Dyshlovoy, S A; Venz, S; Shubina, L K; Fedorov, S N; Walther, R; Jacobson, C; Stonik, V A; Bokemeyer, C; Balabanov, S; Honecker, F (2014). Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancer. Journal of Proteomics, 96:223-239.

Balmer, M L; Schürch, C M; Saito, Y; Geuking, M B; Li, H; Cuenca, M; Kovtonyuk, L V; Mc Coy, K D; Hapfelmeier, S; Ochsenbein, A F; Manz, M G; Slack, E; Mcpherson, A J (2014). Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling. Journal of Immunology, 193(10):5273-5283.

Peters, Solange; Weder, Walter; Dafni, Urania; Kerr, Keith M; Bubendorf, Lukas; Meldgaard, Peter; O'Byrne, Kenneth J; Wrona, Anna; Vansteenkiste, Johan; Felip, Enriqueta; Marchetti, Antonio; Savic, Spasenija; Lu, Shun; Smit, Egbert; Dingemans, Anne-Marie; Blackhall, Fiona H; Baas, Paul; Camps, Carlos; Rosell, Rafael; Stahel, Rolf A (2014). Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters. Journal of Thoracic Oncology, 9(11):1675-1684.

Ning, Yan; Gerger, Armin; Zhang, Wu; Hanna, Diana L; Yang, Dongyun; Winder, Thomas; Wakatsuki, Takeru; Labonte, Melissa J; Stintzing, Sebastian; Volz, Nico; Sunakawa, Yu; Stremitzer, Stefan; El-Khoueiry, Rita; Lenz, Heinz-Josef (2014). Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy. Molecular Cancer Therapeutics, 13(2):528-539.

Lundberg, P; Takizawa, H; Kubovcakova, L; Guo, G; Hao-Shen, H; Dirnhofer, S; Orkin, S H; Manz, M G; Skoda, R C (2014). Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F. Nature Cell Biology, 211(11):2213-2230.

Kroes, Jaap M H; Pietrucci, Fabio; Curioni, Alessandro; Andreoni, Wanda (2014). Characterizing and understanding divalent adsorbates on carbon nanotubes with ab initio and classical approaches: size, chirality, and coverage effects. Journal of Chemical Theory and Computation, 10(10):4672-4683.

Braig, M; Pällmann, N; Preukschas, M; Steinemann, D; Hofmann, W; Gompf, A; Streichert, T; Braunschweig, T; Copland, M; Rudolph, K L; Bokemeyer, C; Koschmieder, S; Schuppert, A; Balabanov, S; Brümmendorf, T H (2014). A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells. Leukemia, 28(10):2028-2039.

Biswas, A; Ivaskevicius, V; Thomas, A; Varvenne, M; Brand, B; Rott, H; Haussels, I; Ruehl, H; Scholz, Ute; Klamroth, R; Oldenburg, J (2014). Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function. Annals of Hematology, 93(10):1665-1676.

Wehrli, M; Goede, J S (2014). Primäre Immunthrombozytopenie (ITP). Praxis, 103(9):485-494.

Güngör, T; Teira, P; Slatter, M; Stussi, G; Stepensky, P; Moshous, D; Vermont, C; Ahmad, I; Shaw, P J; da Cunha, J M; Schlegel, P G; Hough, R; Fasth, A; Kentouche, K; Gruhn, B; Fernandes, J F; Lachance, S; Bredius, R; Resnick, I B; Belohradsky, B H; Gennery, A; Fischer, A; Gaspar, H B; Schanz, U; Seger, R; Rentsch, K; Veys, P; Haddad, E; Albert, M H; Hassan, M (2014). Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet, 383(9915):436-448.

Scharl, M; Bode, B; Rushing, E; Knuth, A; Rordorf, Tamara (2014). Uncommon case of brain metastasis in a patient with a history of heavy smoking. Current Oncology, 21:e728-731.

Florek, M; Sega, E I; Leveson-Gower, D B; Baker, J; Müller, A M; Schneidawind, D; Meyer, E; Negrin, R S (2014). Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models. Blood, 124(11):1832-1842.

Blackhall, Fiona H; Peters, Solange; Bubendorf, Lukas; Dafni, Urania; Kerr, Keith M; Hager, Henrik; Soltermann, Alex; O'Byrne, Kenneth J; Dooms, Christoph; Sejda, Aleksandra; Hernández-Losa, Javier; Marchetti, Antonio; Savic, Spasenija; Tan, Qiang; Thunnissen, Erik; Speel, Ernst-Jan M; Cheney, Richard; Nonaka, Daisuke; de Jong, Jeroen; Martorell, Miguel; Letovanec, Igor; Rosell, Rafael; Stahel, Rolf A (2014). Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project. Journal of Clinical Oncology, 32(25):2780-2787.

Kirsch, M; Götz, A; Halter, J P; Schanz, U; Stussi, G; Dobbels, F; De Geet, S (2014). Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study. Bone Marrow Transplantation, 49(9):1223-1230.

Popescu, R; Ciardiello, F; Stahel, R (2014). Reply to the letter to the editor 'Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper' by Valentini et al. Annals of Oncology, 25(9):1865.

Soldini, Davide; Georgis, Antoin; Montagna, Chiara; Schüffler, Peter Johannes; Martin, Vittoria; Curioni-Fontecedro, Alessandra; Martinez, Antonio; Tinguely, Marianne (2014). The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas. Hematological oncology, 32(3):120-125.

Boettcher, S; Gerosa, R C; Radpour, R; Bauer, J; Ampenberger, F; Heikenwalder, M; Kopf, M; Manz, M G (2014). Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis. Blood, 124(9):1393-1403.

Wellbrock, J; Sheikhzadeh, S; Oliveira-Ferrer, L; Stamm, H; Hillebrand, M; Keyser, B; Klokow, M; Vohwinkel, G; Bonk, V; Otto, B; Streichert, T; Balabanov, S; Hagel, C; Rybczynski, M; Bentzien, F; Bokemeyer, C; von Kodolitsch, Y; Fiedler, W (2014). Overexpression of Gremlin-1 in patients with Loeys-Dietz syndrome: Implications on pathophysiology and early disease detection. PLoS ONE, 9(8):e104742.

Joerger, M; Baty, F; Früh, M; Droege, C; Stahel, R A; Betticher, D C; von Moos, R; Ochsenbein, A; Pless, M; Gautschi, O; Rothschild, S; Brauchli, P; Klingbiel, D; Zappa, F; Brutsche, M (2014). Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung Cancer, 85(2):306-313.

Sendoel, A; Maida, S; Zheng, X; Teo, Y; Stergiou, L; Rossi, C A; Subasic, D; Pinto, S M; Kinchen, J M; Shi, M; Boettcher, S; Meyer, J N; Manz, M G; Bano, D; Hengartner, M O (2014). DEPDC1/LET-99 participates in an evolutionarily conserved pathway for anti-tubulin drug-induced apoptosis. Nature Cell Biology, 16(8):812-820.

Pfirrmann, M; Saussele, S; Hochhaus, A; Reiter, A; Berger, U; Hossfeld, D K; Nerl, C; Scheid, C; Spiekermann, K; Mayer, J; Hellmann, A; Lechner, K; Falge, C; Sayer, H G; Bunjes, D; Ganser, A; Beelen, D W; Baldomero, H; Schanz, U; Heimpel, H; Kolb, H J; Hasford, J; Gratwohl, A; Hehlmann, R (2014). Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia. Journal of Cancer Research and Clinical Oncology, 140(8):1367-1381.

Curioni-Fontecedro, A; Soldini, D; Seifert, B; Eichmueller, T; Korol, D; Moch, H; Weder, W; Stahel, R (2014). A Comprehensive Analysis of Markers for Neuroendocrine Tumors of the Lungs Demonstrates Estrogen Receptor Beta to be a Prognostic Markers in SCLC Male Patients. Journal of Cytology & Histology:5:268.

Hänggi, Pascal; Makhro, Asya; Gassmann, Max; Schmugge, Markus; Goede, Jeroen S; Speer, Oliver; Bogdanova, Anna (2014). Red blood cells of sickle cell disease patients exhibit abnormally high abundance of N-methyl D-aspartate receptors mediating excessive calcium uptake. British Journal of Haematology, 167(2):252-264.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri M; Szucs, Thomas; Schwenkglenks, Matthias; Pestalozzi, Bernhard C (2014). Delivery of health care at the end of life in cancer patients of four swiss cantons a retrospective database study (SAKK 89/09). BMC Cancer, 14:306.

Dirven, Linda; Taphoorn, Martin J B; Reijneveld, Jaap C; Blazeby, Jane; Jacobs, Marc; Pusic, Andrea; La Sala, Edoardo; Stupp, Roger; Fayers, Peter; Efficace, Fabio (2014). The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: A systematic review. European Journal of Cancer, 50(14):2432-2448.

Bolisetty, S; Boddupalli, C S; Handschin, S; Chaitanya, K; Adamcik, J; Saito, Y; Manz, M G; Mezzenga, R (2014). Amyloid fibrils enhance transport of metal nanoparticles in living cells and induced cytotoxicity. Biomacromolecules, 15(7):2793-2799.

Beyer, Jörg (2014). Miracles don`t happen any more. Annals of Oncology, 25(9):1679-1680.

Patton, S; Normanno, N; Blackhall, F; Murray, S; Kerr, K M; Dietel, M; Filipits, M; Benlloch, S; Popat, S; Stahel, R; Thunnissen, E (2014). Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. British Journal of Cancer, 111(2):413-420.

Lohmann, F; Sachs, M; Meyer, T N; Sievert, H; Lindenmeyer, M T; Wiech, T; Cohen, C D; Balabanov, S; Stahl, R A; Meyer-Schwesinger, C (2014). UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation. BBA - Biochimica et Biophysica Acta, 1842(7):945-958.

Gazit, R; Mandal, P K; Ebina, W; Ben-Zvi, A; Nombela-Arrieta, C; Silberstein, L E; Rossi, D J (2014). Fgd5 identifies hematopoietic stem cells in the murine bone marrow. Journal of Experimental Medicine, 211(7):1315-1331.

Dunet, V; Maeder, P; Nicod-Lalonde, M; Lhermitte, B; Pollo, C; Bloch, J; Stupp, R; Meuli, R; Prior, O J (2014). Combination of MRI and dynamic FET PET for initial glioma grading. Nuklearmedizin. Nuclear medicine, 53(4):155-161.

Ciardiello, F; Arnold, D; Casali, P G; Cervantes, A; Douillard, J-Y; Eggermont, A; Eniu, A; McGregor, K; Peters, S; Piccart, M; Popescu, R; Van Cutsem, E; Zielinski, C; Stahel, R (2014). Delivering Precision Medicine in Oncology Today and in Future-The Promise and Challenges of Personalised Cancer Medicine: a position paper by the European Society for Medical Oncology (ESMO). Annals of Oncology, 25(9):1673-1678.

Lacombea, Denis; Burocka, Susen; Bogaertsa, Jan; Schoeffskib, Patrick; Golfinopoulosa, Vassilis; Stupp, Roger (2014). The dream and reality of histology agnostic cancer clinical trials. Molecular Oncology, 8(6):1057-1063.

Muendlein, Axel; Hubalek, Michael; et al (2014). Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients. European Journal of Cancer, 50(12):2134-2141.

Benz, R; Gerber, B (2014). Lots of clots and rods. British Journal of Haematology, 165(6):744-?.

Stupp, R; Weller, M (2014). Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target. Neuro-Oncology, 16(6):765-767.

Liu, Yan; Lacombe, Denis; Stupp, Roger (2014). The changing world of drug development: an academic research organization's perspective on the "Seven Wonders" of the future world of anticancer drug development. Chinese Clinical Oncology, 3(2):19.

Matter-Walstra, Klazien; Klingbiel, Dirk; Szucs, Thomas; Pestalozzi, Bernhard C; Schwenkglenks, Matthias (2014). Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied? Pharmacoeconomics, 32(6):591-599.

Hohla, Florian; Winder, Thomas; Greil, Richard; Rick, Ferenc G; Block, Norman L; Schally, Andrew V (2014). Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives. World Journal of Gastroenterology, 20(20):6102-6112.

Besse, B; Adjei, A; Baas, P; Meldgaard, P; Nicolson, M; Paz-Ares, L; Reck, M; Smit, E F; Syrigos, K; Stahel, R; Felip, E; Peters, S (2014). 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease. Annals of Oncology, 25(8):1475-1484.

Vansteenkiste, J; Crinò, L; Dooms, C; Douillard, J Y; Faivre-Finn, C; Lim, E; Rocco, G; Senan, S; Van Schil, P; Veronesi, G; Stahel, R; Peters, S; Felip, E (2014). 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Annals of Oncology, 25(8):1462-1474.

Müller, A M; Poyser, J; Küpper, N J; Burnett, C; Ko, R M; Kohrt, H E; Florek, M; Zhang, P; Negrin, R S (2014). Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment. Blood, 123(18):2882-2892.

Manz, M G; Boettcher, S (2014). Emergency granulopoiesis. Nature Reviews. Immunology, 14:302-14.

Gilbert, Mark R; Dignam, James; Pugh, Stephanie; Armstrong, Terri S; Wefel, Jeffrey S; Aldape, K; Stupp, Roger; Hegi, Monika; Won, Minhee; Curran, Walter J; Mehta, Minesh (2014). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 32(15):1634-1635.

Kerr, K M; Bubendorf, L; Edelman, M J; Marchetti, A; Mok, T; Novello, S; O'Byrne, K; Stahel, R; Peters, S; Felip, E (2014). Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Annals of Oncology, 25(9):1681-1690.

Berres, M L; Lim, K P; Peters, T; Price, J; Takizawa, H; Salmon, H; Idoyaga, J; Ruzo, A; Lupo, P J; Hicks, M J; Shih, A; Simko, S J; Abhyankar, H; Chakraborty, R; Leboeuf, M; Beltrao, M; Lira, S A; Heym, K M; Bigley, V; Collin, M; Manz, M G; McClain, K; Merad, M; Allen, C E (2014). BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. Journal of Experimental Medicine, 211(4):669-683.

McHugh, Kirsty; Rysnik, Oliwia; Kollnberger, Simon; Shaw, Jacqueline; Utriainen, Lotta; Al-Mossawi, Mohammad Hussein; Payeli, Sravan; Marroquin, Osiris; Milling, Simon; Renner, Christoph; Bowness, Paul (2014). Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply. Annals of the Rheumatic Diseases, 73(4):763-770.

Felley-Bosco, Emanuela; Stahel, Rolf (2014). Hippo/YAP pathway for targeted therapy. Translational Lung Cancer Research, 3(2):75-83.

Berger, M D; Meisel, A; Andres, M; Schanz, U; Schwarz, U; Stussi, G (2014). Unusual case of progressive multifocal leukoencephalopathy after allogeneic hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 32(9):e33-e34.

Strassberger, V; Gutbrodt, K L; Krall, N; Roesli, C; Takizawa, H; Manz, M G; Fugmann, T; Neri, D (2014). A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development. Journal of Proteomics, 99:138-151.

Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A (2014). A functional germline variant in GLI1 implicates Hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients. Clinical Cancer Research, 20(6):1687-1697.

Balabanov, S; Braig, M; Brümmendorf, T H (2014). Current aspects in resistance against tyrosine kinase inhibitors in chronic myelogenous leukemia. Drug Discovery Today: Technologies, 11:89-99.

Shakhova, Olga (2014). Neural crest stem cells in melanoma development. Current Opinion in Oncology, 26(2):215-221.

Berger, Lars A; Bokemeyer, Carsten; Lorch, Anja; Hentrich, Marcus; Kopp, Hans‑Georg; Gauler, Thomas C; Beyer, Jörg; de Wit, Maike; Mayer, Frank; Boehlke, Ina; Oing, Christoph; Honecker, Friedemann; Oechsle, Karin (2014). First salvage treatment in patients with advanced germ cell cancer after cisplatin‑based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG). Journal of Cancer Research and Clinical Oncology, 140(7):1211-1220.

Bitanihirwe, Byron K Y; Meerang, Mayura; Friess, Martina; Soltermann, Alex; Frischknecht, Lukas; Thies, Svenja; Felley-Bosco, Emanuela; Tsao, Ming-Sound; Allo, Ghassan; de Perrot, Marc; Seifert, Burkhardt; Moch, Holger; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2014). PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy. Journal of Thoracic Oncology, 9(2):239-247.

Popescu, R A; Schäfer, R; Califano, R; Eckert, R; Coleman, R; Douillard, J-Y; Cervantes, A; Casali, P G; Sessa, C; Van Cutsem, E; de Vries, E; Pavlidis, N; Fumasoli, K; Wörmann, B; Samonigg, H; Cascinu, S; Cruz Hernández, J J; Howard, A J; Ciardiello, F; Stahel, R A; Piccart, M (2014). The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO). Annals of Oncology, 25(1):9-15.

Müller, Antonia M; Florek, Mareike (2014). 5-Azacytidine/5-Azacitidine. Recent Results in Cancer Research, 201:299-324.

Sievert, H; Pällmann, N; Miller, K K; Hermanns-Borgmeyer, I; Venz, S; Sendoel, A; Preukschas, M; Schweizer, M; Boettcher, S; Janiesch, P C; Streichert, T; Walther, R; Hengartner, M O; Manz, M G; Brümmendorf, T H; Bokemeyer, C; Braig, M; Hauber, J; Duncan, K E; Balabanov, S (2014). A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformation. Disease Models & Mechanisms, 7(8):963-976.

Tonder, Michaela; Eisele, Günter; Weiss, Tobias; Hofer, Silvia; Seystahl, Katharina; Valavanis, Antonios; Stupp, Roger; Weller, Michael; Roth, Patrick (2014). Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. Acta Oncologica, 53(10):1436-1440.

Lenggenhager, Daniela; Curioni-Fontecedro, Alessandra; Storz, Martina; Shakhova, Olga; Sommer, Lukas; Widmer, Daniel S; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; Mihic-Probst, Daniela (2014). An aggressive hypoxia related subpopulation of melanoma cells is TRP-2 Negative. Translational Oncology, 7(2):206-212.

Rordorf, T; Hassan, A A; Azim, H; Alexandru, H; Er, O; Gokmen, E; Güral, Z; Mardiak, J; Minchev, V; Peintinger, F; Szendroi, M; Takac, I; Tesarova, P; Vorobiof, D; Vrbanec, D; Yildiz, R; Yücel, S; Zekri, J; Oyan, B (2014). Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup. Breast, 23(5):511-525.

Otterstrom, C; Soltermann, A; Opitz, I; Felley-Bosco, E; Weder, W; Stahel, R A; Triponez, F; Robert, J H; Serre-Beinier, V (2014). CD74: a new prognostic factor for patients with malignant pleural mesothelioma. British Journal of Cancer, 110(8):2040-2046.

Steiner, Raphael; Beyer, Jörg (2014). CME. Suivi post-traitement des patients atteints d'une néoplasie testiculaire pour les médecins de premiers recours. Praxis, 103(3):125-132.

Bircher, Lukas; Theusinger, Oliver M; Locher, Silvan; Eugster, Philipp; Roth-Z'graggen, Birgit; Schumacher, Christoph M; Studt, Jan-Dirk; Stark, Wendelin J; Beck-Schimmer, Beatrice; Herrmann, Inge K (2014). Characterization of carbon-coated magnetic nanoparticles using clinical blood coagulation assays: Effect of PEG-functionalization and comparison to silica nanoparticles. Journal of Materials Chemistry B, 2(24):3753-3758.

Stupp, R; Hegi, M E; Gorlia, T; et al; Kim, C Y; Nabors, L B; Reardon, D A; van den Bent, M J; Hicking, C; Markivskyy, A; Picard, M; Weller, M (2014). Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncology, 15(10):1100-1108.

Eisele, G; Wick, A; Eisele, A C; Clément, P M; Tonn, J; Tabatabai, G; Ochsenbein, A; Schlegel, U; Neyns, B; Krex, D; Simon, M; Nikkhah, G; Picard, M; Stupp, R; Wick, W; Weller, M (2014). Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression. Journal of Neuro-Oncology, 117(1):141-145.

Hundsberger, T; Tonder, M; Hottinger, A; Brügge, D; Roelcke, U; Putora, P M; Stupp, R; Weller, M (2014). Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients. Journal of Neuro-Oncology, 118(2):321-328.

Barysch, Marjam J; Levesque, Mitchell P; Cheng, Phil; Karpova, Maria B; Mihic-Probst, Daniela; Civenni, Gianluca; Shakhova, Olga; Sommer, Lukas; Biedermann, Thomas; Schiestl, Clemens; Dummer, Reinhard (2014). Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in large to giant congenital melanocytic nevi of pediatric patients. Dermatopathology, 1(1):35-46.

Stein, P; Bosshart, M; Brand, B; Schlicker, A; Spahn, D R; Bettex, D (2014). Dabigatran anticoagulation and Stanford type A aortic dissection: lethal coincidence: Case report with literature review. Acta anaesthesiologica Scandinavica, 58(5):630-637.

Petrausch, Ulf; Pestalozzi, Bernhard C (2014). Der Krebs auf dem Bremspedal des Immunsystems. Swiss Medical Forum, 14(3):32-34.

Franzen, Daniel; Diebold, Matthias; Soltermann, Alex; Schneiter, Didier; Kestenholz, Peter; Stahel, Rolf; Weder, Walter; Kohler, Malcolm (2014). Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort study. BMC Pulmonary Medicine, 14:138.

Rongvaux, A; Willinger, T; Martinek, J; Strowig, T; Gearty, S V; Teichmann, L L; Saito, Y; Marches, F; Halene, S; Palucka, A K; Manz, M G; Flavell, R A (2014). Development and function of human innate immune cells in a humanized mouse model. Nature Biotechnology, 32(4):364-372.

Gerber, Bernhard; Köppel, Jan; Paul, Michaela; Nguyen-Kim, Thi Dan Linh; Frauenfelder, Thomas; Nair, Gayathri; Schanz, Urs; Manz, Markus G (2014). Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: A real-world, retrospective comparative single-centre study. Swiss Medical Weekly, 144:w13985.

Lacombe, Denis; Tejpar, Sabine; Salgado, Roberto; Cardoso, Fatima; Golfinopoulos, Vassilis; Aust, Daniela; Folprecht, Gunnar; Roth, Arnaud; Stupp, Roger (2014). European perspective for effective cancer drug development. Nature Reviews. Clinical Oncology, 11(8):492-498.

Wueest, S; Mueller, R; Blüher, M; Item, F; Chin, A S; Wiedemann, M S; Takizawa, H; Kovtonyuk, L; Chervonsky, A V; Schoenle, E J; Manz, M G; Konrad, D (2014). Fas (CD95) expression in myeloid cells promotes obesity-induced muscle insulin resistance. EMBO Molecular Medicine, 6(1):43-56.

Renganathan, Arun; Kresoja-Rakic, Jelena; Echeverry, Nohemy; Ziltener, Gabriela; Vrugt, Bart; Opitz, Isabelle; Stahel, Rolf A; Felley-Bosco, Emanuela (2014). GAS5 long non-coding RNA in malignant pleural mesothelioma. Molecular Cancer, 13:119.

Zikos, Efstathios; Ghislain, Irina; Coens, Corneel; Ediebah, Divine E; Sloan, Elizabeth; Quinten, Chantal; Koller, Michael; van Meerbeeck, Jan P; Flechtner, Hans-Henning; Stupp, Roger; Czimbalmos, Agnes; Sprangers, Mirjam A G; Bottomley, Andrew (2014). Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials. Lancet Oncology, 15(2):e78-e89.

Beeler, P E; Eschmann, E; Schumacher, A; Studt, J-D; Amann-Vesti, B; Blaser, J (2014). Impact of electronic reminders on venous thromboprophylaxis after admissions and transfers. Journal of the American Medical Informatics Association (JAMIA), (21):e297-e303.

Winder, T; Giamas, G; Wilson, P M; Zhang, W; Bohanes, P; Ning, Y; Gerger, A; Stebbing, J; Lenz, H-J (2014). Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients Q1 treated with tamoxifen. Pharmacogenomics Journal, 14:28-34.

Rossetti, A O; Jeckelmann, S; Novy, J; Roth, P; Weller, M; Stupp, R (2014). Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro-Oncology, 16(4):584-588.

Pecci, A; Klersy, C; Gresele, P; Lee, K J; De Rocco, D; Bozzi, V; Russo, G; Heller, P G; Loffredo, G; Ballmeier, M; Fabris, F; Beggiato, E; Kahr, W H; Pujol-Moix, N; Platokouki, H; Van Geet, C; Noris, P; Yerram, P; Hermans, C; Gerber, B; Economou, M; De Groot, M; Zieger, B; De Candia, E; Fraticelli, V; Kersseboom, R; Piccoli, G C; Zimmermann, S; Fierro, T; Glembotsky, A C; Vianello, F; Zaninetti, C; Nicchia, E; Güthner, C; Baronci, C; Seri, M; Knight, P J; Balduini, C I; Savoia, A (2014). MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. Human Mutation, 35(2):236-247.

Rechsteiner, Markus; Müller, Rouven; Reineke, Tanja; Goede, Jeroen; Bohnert, Annette; Zhong, Qing; Manz, Markus G; Moch, Holger; Wild, Peter J; Zimmermann, Dieter R; Tinguely, Marianne (2014). Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by next generation sequencing. Experimental Hematology & Oncology, 3:18.

Winder, Thomas; Pestalozzi, Bernhard C (2014). RASante Entwicklung bei der Therapie des kolorektalen Karzinoms. Swiss Medical Forum:49-51.

Benz, R; Schanz, U; Maggiorini, M; Seebach, J D; Stussi, G (2014). Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplantation, 49(1):62-65.

Wagner, Claudia C; Held, Ulrike; Kofmehl, Reto; Battegay, Edouard; Zimmerli, Lukas; Hofer, Silvia (2014). Role of arterial hypertension as a predictive marker for bevacizumab efficacy in recurrent glioblastoma - a prospective analysis. Acta Oncologica, 53(4):572-575.

Hottinger, Andreas F; Stupp, Roger; Homicsko, Krisztian (2014). Standards of care and novel approaches in the management of glioblastoma multiforme. Chinese Journal of Cancer, 33(1):32-39.

Peters, Solange; Stahel, R A (2014). Successes and limitations of targeted cancer therapy. Basel: Karger.

Steiner, Raphael; Beyer, Jörg (2014). Suivi post-traitement des patients atteints d'une néoplasie testiculaire pour les médecins de premiers recours. Praxis, 103(3):125-132.

Kasenda, Benjamin; Bass, Annatina; Koeberle, Dieter; Pestalozzi, Bernhard; Borner, Markus; Herrmann, Richard; Jost, Lorenz; Lohri, Andreas; Hess, Viviane (2014). Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study. BMC Cancer, 14:728.

Rauch, P J; Müllhaupt, B; Biedermann, L; Manz, M G; Ruschitzka, F; Flammer, A; Segerer, S T; Mohebbi, N; Jung, H H; Moch, H; Ikenberg, K; Aguzzi, A; Nuvolone, M; Distler, O; Rauch, A; Fehr, T H; Gerber, B (2014). Systemische Amyloidosen. Swiss Medical Forum, 14(50):943-948.

Kondziolka, Douglas; Parry, Phillip V; Lunsford, L Dade; Kano, Hideyuki; Flickinger, John C; Rakfal, Susan; Arai, Yoshio; Loeffler, Jay S; Rush, Stephen; Knisely, Jonathan P S; Sheehan, Jason; Friedman, William; Tarhini, Ahmad A; Francis, Lanie; Lieberman, Frank; Ahluwalia, Manmeet S; Linskey, Mark E; McDermott, Michael; Sperduto, Paul; Stupp, Roger (2014). The accuracy of predicting survival in individual patients with cancer. Journal of Neurosurgery, 120(1):24-30.

Marek, A; Stern, M; Chalandon, Y; Ansari, M; Ozsahin, H; Güngör, T; Gerber, B; Kühne, T; Passweg, J R; Gratwohl, A; Tichelli, A; Seger, R; Schanz, U; Halter, J; Stussi, G (2014). The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT. Bone Marrow Transplantation, 49(1):55-61.

Marek, A. The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic stem cell transplantation. 2014, University of Zurich, Faculty of Medicine.

Roth, P; Stupp, R; Eisele, G; Weller, M (2014). Treatment of primary CNS lymphoma. Current Treatment Options in Neurology, 16(1):277.

Kotov, Ilya N; Siebring-van Olst, Ellen; Knobel, Philip A; van der Meulen-Muileman, Ida H; Felley-Bosco, Emanuela; van Beusechem, Victor W; Smit, Egbert F; Stahel, Rolf A; Marti, Thomas M (2014). Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress. Molecular Oncology, 8(8):1747-1759.

Samaras, Panagiotis. Aggressive Lymphome: Moderne Behandlung und risikoadaptierte Nachsorge. 2013, University of Zurich, Faculty of Medicine.

Stahel, Rolf; Peters, Solange; Baas, Paul; Brambilla, Elisabeth; Cappuzzo, Federico; De Ruysscher, Dirk; Eberhardt, Wilfried Ernst Erich; Felip, Enriqueta; Fennell, Dean; Marchetti, Antonio; Paz-Ares, Luis; Adjei, Alex A (2013). Strategies for improving outcomes in NSCLC: a look to the future. Lung Cancer, 82(3):375-382.

Terwijn, M; van Putten, W L; Kelder, A; van der Velden, V H; Brooimans, R A; Pabst, T; Maertens, J; Boeckx, N; de Greef, G E; Valk, P J; Preijers, F W; Huijgens, P C; Dräger, A M; Schanz, U; Jongen-Lavrecic, M; Biemond, B J; Passweg, J R; van Gelder, M; Wijermans, P; Graux, C; Bargetzi, M; Legdeur, M C; Kuball, J; de Weerdt, O; Chalandon, Y; Hess, U; Verdonck, L F; Gratama, J W; Oussoren, Y J; Scholten, W J; Slomp, J; Snel, A N; Vekemans, M C; Löwenberg, B; Ossenkoppele, G J; Schuurhuis, G J (2013). High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: Data from the HOVON/SAKK AML 42A Study. Journal of Clinical Oncology, 31(31):3889-3897.

Petrausch, Ulf. Entwicklung Antigen-spezifischer Immuntherapien. 2013, University of Zurich, Faculty of Medicine.

Hauber, I; Hofmann-Sieber, H; Chemnitz, J; Dubrau, D; Chusainow, J; Stucka, R; Hartjen, P; Schambach, A; Ziegler, P; Hackmann, K; Schröck, E; Schumacher, U; Lindner, C; Grundhoff, A; Baum, C; Manz, M G; Buchholz, F; Hauber, J (2013). Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice. PLoS Pathogens, 9(9):e1003587.

Lentz, S R; Misgav, M; Ozelo, M; Salek, S Z; Veljkovic, D; Recht, M; Cerquira, M; Tiede, A; Brand, B; Mancuso, M E; Seremetis, S; Lindblom, A; Martinovic, U (2013). Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia, 19(5):691-697.

Hayoz, Stefanie; Klingbiel, Dirk; Brauchli, Peter; von Moos, Roger (2013). What can we learn from the ZOOM trial? Lancet Oncology, 14(10):e388.

Schlenk, R F; Taskesen, E; van Norden, Y; Krauter, J; Ganser, A; Bullinger, L; Gaidzik, V I; Paschka, P; Corbacioglu, A; Göhring, G; Kündgen, A; Held, G; Götze, K; Vellenga, E; Kuball, J; Schanz, U; Passweg, J; Papst, T; Maertens, J; Ossenkoppele, G J; Delwel, R; Döhner, H; Cornelissen, J J; Döhner, K; Löwenberg, B (2013). The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA. Blood, 9(122):1576-1582.

Cozzi, A; Santambrogio, P; Privitera, D; Broccoli, V; Rotundo, L I; Garavaglia, B; Benz, R; Altamura, S; Goede, J S; Muckenthaler, M U; Levi, S (2013). Human L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome. Journal of Experimental Medicine, 210(9):1779-1791.

Peters, Solange; Taron, Miquel; Bubendorf, Lukas; Blackhall, Fiona; Stahel, Rolf (2013). Treatment and detection of ALK-rearranged NSCLC. Lung Cancer, 81(2):145-154.

Saito, Y; Boddupalli, C S; Borsotti, C; Manz, M G (2013). Dendritic cell homeostasis is maintained by nonhematopoietic and T-cell-produced Flt3-ligand in steady state and during immune responses. European Journal of Immunology, 6(43):1651-1658.

Bettens, F; Schanz, U; Tiercy, J M (2013). Lack of recognition of HLA class I mismatches outside α1/α2 domains by CD8+ alloreactive T lymphocytes: the HLA-B44 paradigm. Tissue Antigens, 6(81):414-418.

Pollock, E; Studer, I; Gisler, V; Samaras, Panagiotis (2013). An unusual case of sarcoidosis. In: SGIM Jahresversammlung, Congress Center Basel, 29 May 2013 - 31 May 2013.

Schaller, M; Studt, J D; Voorberg, J; Kremer Hovinga, J A (2013). Acquired thrombotic thrombocytopenic purpura. Development of an autoimmune response. Hämostaseologie, 33(2):121-130.

Studt, J D; Binet, I; Nair, G; Schanz, U (2013). Heparin-induced thrombocytopenia associated with thrombotic microangiopathy. Hämostaseologie, 2(33):160-163.

Lane, J; et al; Brand, B (2013). A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Human Molecular Genetics, 22(9):1903-1910.

Lee, James A; Bubendorf, Lukas; Stahel, Rolf; Peters, Solange (2013). Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives. Expert Review of Anticancer Therapy, 13(5):625-36.

Tiede, A; Brand, B; Fischer, R; Kavakli, K; Lentz, S R; Matsushita, T; Rea, C; Knobe, K; Viuff, D (2013). Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A. Journal of Thrombosis and Haemostasis, 11(4):670-678.

Schwotzer, R; Goede, J S; Franzen, D (2013). Erythrozytose. Praxis:317-326.

Goede, J S; Siciliano, D R (2013). Der splenektomierte Patient in der Praxis. Therapeutische Umschau. Revue thérapeutique, 70(3):185-188.

Scotti, C; Piccinini, E; Takizawa, H; Todorov, A; Bourqine, P; Papadimitropoulos, A; Barbero, A; Manz, M G; Martin, I (2013). Engineering of a functional bone organ through endochondral ossification. Proceedings of the National Academy of Sciences of the United States of America, 10(110):3997-4002.

Passweg, J R; Baldomero, H; Bargetzi, M; Bucher, C; Chalandon, Y; Duchosal, M A; Gratwohl, A; Güngör, T; Hess, U; Leibundgut, K; de Faveri, G N; Ozsahin, H; Pabst, T; Renner, C; Stern, M; Stussi, G; Schanz, U (2013). Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries. Swiss Medical Weekly, 143:w13757.

von Kanel, T; Röthlisberger, B; Schanz, U; Dutly, F; Huber, A R; Saller, E (2013). A Swiss (εγδβ)(0) -thalassemia patient with a novel 3-Mb deletion associated with mild mental impairment. American Journal of Hematology, 88(2):158-159.

von Kanel, T; Röthlisberger, B; Schanz, U; Dutly, F; Huber, A R; Saller, E (2013). A Swiss (εγδβ)⁰-thalassemia patient with a novel 3-Mb deletion associated with mild mental impairment. American Journal of Hematology, 88(2):158-159.

Balabanov, S; Wilhelm, T; Venz, S; Keller, G; Scharf, C; Pospisil, H; Braig, M; Barett, C; Bokemeyer, C; Walther, R; Brümmendorf, T H; Schuppert, A (2013). Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors. PLoS ONE, 8(1):e53668.

Harris, Melissa L; Buac, Kristina; Shakhova, Olga; Hakami, Ramin M; Wegner, Michael; Sommer, Lukas; Pavan, William J (2013). A dual role for Sox10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors. PLoS Genetics, 9(7):e1003644.

Soldini, D; Montagna, C; Schüffler, P; Martin, V; Georgis, A; Thiesler, T; Curioni-Fontecedro, A; Went, P; Bosshard, G; Dehler, Silvia; Mazzuchelli, L; Tinguely, M (2013). A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome. Annals of Oncology, 24(1):193-201.

Gupta, Anurag; Nuber, Natko; Esslinger, Christoph; Wittenbrink, Mareike; Treder, Martin; Landshammer, Alexandro; Noguchi, Takuro; Kelly, Marcus; Gnjatic, Sacha; Ritter, Erika; von Boehmer, Lotta; Nishikawa, Hiroyoshi; Shiku, Hiroshi; Old, Lloyd; Ritter, Gerd; Knuth, Alexander; van den Broek, Maries (2013). A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy. Cancer Immunity, 13:3.

Connor, Joseph P; Cristea, Mihaela C; Lewis, Nancy L; Lewis, Lionel D; Komarnitsky, Philip B; Mattiacci, Maria R; Felder, Mildred; Stewart, Sarah; Harter, Josephine; Henslee-Downey, Jean; Kramer, Daniel; Neugebauer, Roland; Stupp, Roger (2013). A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors. BMC Cancer, 13:20.

Walter, Anne; Schäfer, Matthias; Cecconi, Virginia; Matter, Claudia; Urosevic-Maiwald, Mirjana; Belloni, Benedetta; Schönewolf, Nicola; Dummer, Reinhard; Bloch, Wilhelm; Werner, Sabine; Beer, Hans-Dietmar; Knuth, Alexander; van den Broek, Maries (2013). Aldara activates TLR7-independent immune defence. Nature Communications, 4:1560.

Gerull, S; Stern, M; Ben Aissa, A; Manz, M G; Schanz, U; Stussi, G; Chalandon, Y; Passweg, J; Mohty, B (2013). Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT. Bone Marrow Transplantation, 48(3):408-413.

Jakka, Gopinadh; Schuberth, Petra C; Thiel, Markus; Held, Gerhard; Stenner, Frank; van den Broek, Maries; Renner, Christoph; Mischo, Axel; Petrausch, Ulf (2013). Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system. Anticancer Research, 33(10):4189-4201.

Stupp, Roger; Hegi, Monika E (2013). Brain cancer in 2012: Molecular characterization leads the way. Nature Reviews. Clinical Oncology, 10(2):69-70.

Doroshow, James H; Sleijfer, Stefan; Stupp, Roger; Anderson, Kenneth (2013). Cancer clinical trials - do we need a new algorithm in the age of stratified medicine? The Oncologist, 18(6):651-652.

Sigle, J P; Infanti, L; Studt, J D; Martinez, M; Stern, M; Gratwohl, A; Passweg, J; Tichelli, A; Buser, A S (2013). Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components. Transfusion, 53(8):1788-1797.

Morsbach, Fabian; Pfammatter, Thomas; Reiner, Caecilia S; Fischer, Michael A; Sah, Bert-Ram; Winklhofer, Sebastian; Klotz, Ernst; Frauenfelder, Thomas; Knuth, Alexander; Seifert, Burkhardt; Schaefer, Niklaus; Alkadhi, Hatem (2013). Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Investigative Radiology, 48(11):787-794.

Stenner-Liewen, Frank; Liewen, Heike; Cathomas, Richard; Renner, Christoph; Petrausch, Ulf; Sulser, Tullio; Spanaus, Katharina; Seifert, Hans Helge; Strebel, Räto Thomas; Knuth, Alexander; Samaras, Panagiotis; Müntener, Michael (2013). Daily Pomegranate intake has no impact on PSA levels in patients with advanced prostate cancer - Results of a phase IIb randomized controlled trial. Journal of Cancer, 4(7):597-605.

Huber, F L; Latshang, T D; Goede, J S; Bloch, K E (2013). Does venous blood gas analysis provide accurate estimates of hemoglobin oxygen affinity? Annals of Hematology, 92(4):517-521.

Gilbert, Mark R; Wang, Meihua; Aldape, Kenneth D; Stupp, Roger; Hegi, Monika E; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara; Baumert, Brigitta; Hopkins, Kristen I; Tzuk-Shina, Tzahala; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology, 31(32):4085-4091.

Schuberth, P C; Jakka, G; Jensen, S M; Wadle, A; Gautschi, F; Haley, D; Haile, S; Mischo, A; Held, G; Thiel, M; Tinguely, M; Bifulco, C B; Fox, B A; Renner, C; Petrausch, U (2013). Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma. Gene Therapy, 20(4):386-395.

Zimmermann, Anne-Katrin; Imig, Jochen; Klar, Agnes; Renner, Christoph; Korol, Dimitri; Fink, Daniel; Stadlmann, Sylvia; Singer, Gad; Knuth, Alexander; Moch, Holger; Caduff, Rosmarie (2013). Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas. Virchows Archiv, 462(5):565-574.

Rongvaux, A; Takizawa, H; Strowig, T; Willinger, T; Eynon, E E; Flavell, R A; Manz, M G (2013). Human hemato-lymphoid system mice: current use and future potential for medicine. Annual Review of Immunology, 31:635-674.

Wolfensberger, A; Benz, R; Russi, E W; Tinguely, M; Keller, C; Gerber, B (2013). Husten, Atemnot und B-Symptome bei einer 40-jährigen Frau. Der Internist, 54(8):1011-1015.

Cerciello, Ferdinando; Choi, Meena; Nicastri, Annalisa; Bausch-Fluck, Damaris; Ziegler, Annemarie; Vitek, Olga; Felley-Bosco, Emanuela; Stahel, Rolf; Aebersold, Ruedi; Wollscheid, Bernd (2013). Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring. Clinical Proteomics, 10:16.

Rechsteiner, Markus; von Teichman, Adriana; Rüschoff, Jan H; Fankhauser, Niklaus; Pestalozzi, Bernhard; Schraml, Peter; Weber, Achim; Wild, Peter; Zimmermann, Dieter; Moch, Holger (2013). KRAS, BRAF, and TP53 deep-sequencing for colorectal carcinoma patient diagnostics. Journal of Molecular Diagnostics, 15(3):299-311.

Zimmermann, S; Curioni-Fontecedro, Alessandra; Stahel, R; Peters, S (2013). Lung Cancer. In: Dicato, M A. Side Effects of Medical Cancer Therapy. - Prevention and Treatment. London: Springer-Verlag, 119-138.

Nuber, Natko; Curioni-Fontecedro, Alessandra; Dannenmann, Stefanie R; Matter, C; von Boehmer, Lotta; Atanackovic, Djordje; Knuth, Alexander; van den Broek, Maries (2013). MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients. Leukemia, 27(8):1767-1769.

Tabatabai, Ghazaleh; Stupp, Roger; Wick, Wolfgang; Weller, Michael (2013). Malignant astrocytoma in elderly patients: where do we stand? Current Opinion in Neurology, 26(6):693-700.

Jarzabek, Monika A; Sweeney, Kieron J; Evans, Rhys L; Jacobs, Andreas H; Stupp, Roger; O'Brien, Donncha; Berger, Mitchel S; Prehn, Jochen H M; Byrne, Annette T (2013). Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary. Drug Discovery Today, 18(21-22):1052-1066.

Weller, M; Pfister, S M; Wick, W; Hegi, M E; Reifenberger, G; Stupp, R (2013). Molecular neuro-oncology in clinical practice: a new horizon. Lancet Oncology, 14(9):e370-e379.

Makhro, Asya; Hänggi, Pascal; Goede, Jeroen S; Wang, Jue; Brüggemann, Andrea; Gassmann, Max; Schmugge, Markus; Kaestner, Lars; Speer, Oliver; Bogdanova, Anna (2013). N-methyl-D-aspartate receptors in human erythroid precursor cells and in circulating red blood cells contribute to the intracellular calcium regulation. American journal of Physiology. Cell physiology, 305(11):C1123-C1138.

von Boehmer, Lotta; Mattle, Muriel; Bode, Peter; Landshammer, Alexandro; Schäfer, Carolin; Nuber, Natko; Ritter, Gerd; Old, Lloyd; Moch, Holger; Schäfer, Niklaus; Jäger, Elke; Knuth, Alexander; van den Broek, Maries (2013). NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma. Cancer Immunity, 13:12.

Hegi, Monika E; Stupp, Roger (2013). Neuro-oncology: in search of molecular markers of glioma in elderly patients. Nature Reviews. Neurology, 9(8):424-425.

Gorlia, Thierry; Wu, Wenting; Wang, Meihua; Baumert, Brigitta G; Mehta, Minesh; Buckner, Jan C; Shaw, Edward; Brown, Paul; Stupp, Roger; Galanis, Evanthia; Lacombe, Denis; van den Bent, Martin J (2013). New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro-Oncology, 15(11):1568-1579.

Buchinger, Katharina; Stahel, Rolf; Niggemeier, Verena; Gubler, Christoph; Franzen, Daniel (2013). Pemetrexed-induced neutropenic enteritis and severe cutaneous hyperpigmentation in a patient with malignant pleural mesothelioma. Lung Cancer, 80(3):347-349.

Curioni-Fontecedro, A; Husmann, L; Soldini, D; Stahel, R A (2013). Primary non-small cell lung cancer response upon treatment with denosumab. Lung Cancer, 82(3):506-508.

Samaras, Panagiotis; Zardavas, Dimitrios; Petrausch, Ulf; Buset, Elefteri M; Haile, Sarah R; Honegger, Hanspeter; Siciliano, Raffaele D; Schanz, Urs; Mischo, Axel; Schäfer, Niklaus G; Taverna, Christian; Knuth, Alexander; Stahel, Rolf; Renner, Christoph; Stenner-Liewen, Frank (2013). Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation. Swiss Medical Weekly, 143:w13791.

Balabanov, Stefan; Evans, Caroline A; Abraham, Sheela A; Pellicano, Francesca; Copland, Mhairi; Walker, Michael J; Whetton, Anthony D; Holyoake, Tessa L (2013). Quantitative proteomics analysis of BMS-214662 effects on CD34 positive cells from chronic myeloid leukaemia patients. Proteomics, 13(1):153-168.

Stenner, Frank; Liewen, Heike; Göttig, Stephan; Henschler, Reinhard; Markuly, Norbert; Kleber, Sascha; Faust, Michael; Mischo, Axel; Bauer, Stefan; Zweifel, Martin; Knuth, Alexander; Renner, Christoph; Wadle, Andreas (2013). RP1 is a phosphorylation target of CK2 and is involved in cell adhesion. PLoS ONE, 8(7):e67595.

Sharma, Anu; Bode, Beata; Moch, Holger; Okoniewski, Michal; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries (2013). Radiotherapy of human sarcoma promotes an intratumoral immune effector signature. Clinical Cancer Research, 19(17):4843-4853.

Martens, T; Matschke, J; Müller, C; Riethdorf, S; Balabanov, S; Westphal, M; Heese, O (2013). Skeletal spread of an anaplastic astrocytoma (WHO grade III) and preservation of histopathological properties within metastases. Clinical Neurology and Neurosurgery, 115(3):323-328.

Pfrommer, Sarah; Weber, Achim; Dutkowski, Philipp; Schäfer, Niklaus G; Müllhaupt, Beat; Bourquin, Jean-Pierre; Breitenstein, Stefan; Pestalozzi, Bernhard C; Stenner, Frank; Renner, Christoph; D'Addario, Giannicola; Graf, Hans-Jörg; Knuth, Alexander; Clavien, Pierre-Alain; Samaras, Panagiotis (2013). Successful salvage chemotherapy with FOLFIRINOX for recurrent mixed acinar cell carcinoma and ductal adenocarcinoma of the pancreas in an adolescent patient. Case Reports in Oncology, 6(3):497-503.

Laurent, Julien; Touvrey, Cedric; Gillessen, Silke; Joffraud, Magali; Vicari, Manuela; Bertrand, Caroline; Ongarello, Stefano; Liedert, Bernd; Gallerani, Elisa; Beck, Joachim; Omlin, Aurelius; Sessa, Cristiana; Quaratino, Sonia; Stupp, Roger; Gnad-Vogt, Ulrike S; Speiser, Daniel E (2013). T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein. Journal of Translational Medicine, 11:5.

Shakhova, Olga; Sommer, Lukas (2013). Testing the cancer stem cell hypothesis in melanoma: The clinics will tell. Cancer Letters, 338(1):74-81.

Brandt, Simone; Montagna, Chiara; Georgis, Antoin; Schüffler, Peter J; Bühler, Marco M; Seifert, Burkhardt; Thiesler, Thore; Curioni-Fontecedro, Alessandra; Hegyi, Ivan; Dehler, Silvia; Martin, Vittoria; Tinguely, Marianne; Soldini, Davide (2013). The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma. Experimental Hematology & Oncology, 2:27.

Hofer, Silvia; Pestalozzi, Bernhard C (2013). Treatment of breast cancer brain metastases. European Journal of Pharmacology, 717(1-3):84-87.

Schuberth, Petra C; Hagedorn, Christian; Jensen, Shawn M; Gulati, Pratiksha; van den Broek, Maries; Mischo, Axel; Soltermann, Alex; Jüngel, Astrid; Marroquin Belaunzaran, Osiris; Stahel, Rolf; Renner, Christoph; Petrausch, Ulf (2013). Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells. Journal of Translational Medicine, 11:187.

Dannenmann, Stefanie Regine; Thielicke, Julia; Stöckli, Martina; Matter, Claudia; von Boehmer, Lotta; Cecconi, Virginia; Hermanns, Thomas; Hefermehl, Lukas; Schraml, Peter; Moch, Holger; Knuth, Alexander; van den Broek, Maries (2013). Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma. OncoImmunology, 2(3):e23562.

Gautschi, Oliver; Dingemans, Anne-Marie; Crowe, Susanne; Peters, Solange; Roder, Heinrich; Grigorieva, Julia; Roder, Joanna; Zappa, Francesco; Pless, Miklos; Brutsche, Martin; Baty, Florent; Bubendorf, Lukas; Hsu Schmitz, Shu-Fang; Na, Kyung-Jae; Carbone, David; Stahel, Rolf; Smit, Egbert (2013). VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer, 79(1):59-64.

Gupta, Anurag; Sharma, Anu; von Boehmer, Lotta; Surace, Laura; Knuth, Alexander; van den Broek, Maries (2012). Radiotherapy supports protective tumor-specific immunity. OncoImmunology, 1(9):1610-1611.

Zappa, F; Droege, C; Betticher, D; von Moos, R; Bubendorf, L; Ochsenbein, A; Gautschi, O; Oppliger Leibundgut, E; Froesch, P; Stahel, R; Hess, T; Rauch, D; Schmid, P; Mayer, M; Crowe, S; Brauchli, P; Ribi, K; Pless, M (2012). Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05). Lung Cancer, 78(3):239-244.

Ziegler, P; Chahoud, T; Wilhelm, T; Pällmann, N; Braig, M; Wiehle, V; Ziegler, S; Schröder, M; Meier, C; Kolodzik, A; Rarey, M; Panse, J; Hauber, J; Balabanov, S; Brümmendorf, T H (2012). Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias. Investigational New Drugs, 30(6):2274-2283.

Petrausch, U; Schuberth, P C; Hagedorn, C; Soltermann, A; Tomaszek, S; Stahel, R; Weder, W; Renner, C (2012). Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1). BMC Cancer, 12:615.

Collaud, Stéphane; Stahel, Rolf; Inci, Ilhan; Hillinger, Sven; Schneiter, Didier; Kestenholz, Peter; Weder, Walter (2012). Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. Lung Cancer, 78(3):234-238.

Schäfer, N. Der sinnvolle Einsatz der FDG – PET/CT beim malignen Lymphom. 2012, University of Zurich, Faculty of Medicine.

Fischer, Eliane; Chaitanya, Krishna; Wüest, Thomas; Wadle, Andreas; Scott, Andrew M; van den Broek, Maries; Schibli, Roger; Bauer, Stefan; Renner, Christoph (2012). Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies. Clinical Cancer Research, 18(22):6208-6218.

Breitenstein, A; Sluka, S H; Akhmedov, A; Stivala, S; Steffel, J; Camici, G G; Riem, H H; Beer, H J; Studt, J D; Duru, F; Luscher, T F; Tanner, F C (2012). Dronedarone reduces arterial thrombus formation. Basic Research in Cardiology, 107(6):302.

Brand, B; Graf, L (2012). Neue Antikoagulantien - die direkten Thrombininhibitoren. Therapeutische Umschau. Revue thérapeutique, 69(11):643-649.

Sievert, H; Venz, S; Platas-Barradas, O; Dhople, V M; Schaletzky, M; Nagel, C H; Braig, M; Preukschas, M; Pällmann, N; Bokemeyer, C; Brümmendorf, T H; Pörtner, R; Walther, R; Duncan, K E; Hauber, J; Balabanov, S (2012). Protein-protein-interaction network organization of the hypusine modification system. Molecular & Cellular Proteomics, 11(11):1289-1305.

Payeli, S K; Kollnberger, S; Marroquin Belaunzaran, O; Thiel, M; McHugh, K; Giles, J; Shaw, J; Kleber, S; Ridley, A; Wong-Baeza, I; Keidel, S; Kuroki, K; Maenaka, K; Wadle, A; Renner, C; Bowness, P (2012). Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis. Arthritis & Rheumatism, 64(10):3139-3149.

Fischer, B; Frei, C; Moura, U; Stahel, R; Felley-Bosco, E (2012). Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy. Lung Cancer, 78(1):23-29.

Meyer-Schwesinger, C; Dehde, S; Sachs, M; Mathey, S; Arefi, K; Gatzemeier, S; Balabanov, S; Becker, J U; Thaiss, F; Meyer, T N (2012). Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis. American Journal of Physiology. Renal Physiology, 303(7):F1015-F1025.

Himmelmann, A; Rychter, O; Goede, J S (2012). Anämie im Alter: Wen, wie, warum abklären? Praxis, 101(19):1261-1266.

Pascolo, S. Steering the immumnostimulation profile triggered by single stranded RNA through Toll Like Receptors. 2012, University of Zurich, Faculty of Medicine.

Scharl, M. Von der Entzündung zum Krebs: Wie aus der chronischen Kolitis ein Dickdarmkarzinom entsteht. 2012, University of Zurich, Faculty of Medicine.

Deuel, J W; Lutz, H U; Misselwitz, B; Goede, J S (2012). Asymptomatic elevation of the hyperchromic red blood cell subpopulation is associated with decreased red cell deformability. Annals of Hematology, 91(9):1427-1434.

Hofer, S; Mengele, K; Stemmler, H J; Schmitt, M; Pestalozzi, B (2012). Intrathecal trastuzumab: dose matters. Acta Oncologica, 51(7):955-956.

Schliehe, Christopher; Bitzer, Annegret; van den Broek, Maries; Groettrup, Marcus (2012). Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo. Journal of Virology, 86(18):9782-9793.

Yogev, Nir; Frommer, Friederike; Lukas, Dominika; Kautz-Neu, Kordula; Karram, Khalad; Ielo, Daniele; von Stebut, Esther; Probst, Hans C; van den Broek, Maries; Riethmacher, Dieter; Birnber, Tal; Blank, Thomas; Reizis, Boris; Korn, Thomas; Wiendl, Heinz; Jung, Steffen; Prinz, Marco; Kurschus, Florian C; Waisman, Ari (2012). Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity, 37(2):264-275.

Preukschas, M; Hagel, C; Schulte, A; Weber, K; Lamszus, K; Sievert, H; Pällmann, N; Bokemeyer, C; Hauber, J; Braig, M; Balabanov, S (2012). Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies. PLoS ONE, 7(8):43468.

Widenmeyer, M; Griesemann, H; Stevanović, S; Feyerabend, S; Klein, R; Attig, S; Hennenlotter, J; Wernet, D; Kuprash, D V; Sazykin, A Y; Pascol, S; Stenzl, A; Gouttefangeas, C; Rammensee, H G (2012). Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients. International Journal of Cancer, 131(1):140-149.

Renner, C; Zinzani, P L; Gressin, R; Klingbiel, D; Dietrich, P Y; Hitz, P; Bargetzi, M; Mingrone, W; Martinelli, G; Trojan, A; Bouabdallah, K; Lohri, A; Gyan, E; Biaggi, C; Cogliatti, S; Bertoni, F; Ghielmini, M; Brauchli, P; Ketterer, N (2012). A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica, 97(7):1085-1091.

Ziegler, P; Schrezenmeier, H; Akkad, J; Brassat, U; Vankann, L; Panse, J; Wilop, S; Balabanov, S; Schwarz, K; Martens, U M; Brümmendorf, T H (2012). Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation. Annals of Hematology, 91(7):1115-1120.

Shi, Yandong; Moura, Ubiratan; Opitz, Isabelle; Soltzermann, Alex; Rehrauer, Hubert; Thies, Svenja; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2012). Role of hedgehog signaling in malignant pleural mesothelioma. Clinical Cancer Research, 18(17):4646-4656.

Boettcher, S; Ziegler, P; Schmid, M A; Takizawa, H; van Rooijen, N; Kopf, M; Heikenwälder, M; Manz, M G (2012). Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4-expressing nonhematopoietic cells. Journal of Immunology, 188(12):5824-5828.

Studer, G; Brown, M; Bredell, M; Graetz, K W; Huber, G; Linsenmeier, C; Najafi, Y; Riesterer, O; Rordorf, T; Schmid, S; Glanzmann, C (2012). Follow up after IMRT in oral cavity cancer: update. Radiation Oncology, 7:84.

Engert, A; Haverkamp, H; Kobe, C; Markova, J; Renner, C; Ho, A; Zijlstra, J; Král, Z; Fuchs, M; Hallek, M; Kanz, L; Döhner, H; Dörken, B; Engel, N; Topp, M; Klutmann, S; Amthauer, H; Bockisch, A; Kluge, R; Kratochwil, C; Schober, O; Greil, R; Andreesen, R; Kneba, M; Pfreundschuh, M; Stein, H; Eich, H T; Müller, R P; Dietlein, M; Borchmann, P; Diehl, V (2012). Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet, 379(9828):1791-1799.

Jäger, E; Knuth, A (2012). The discovery of cancer/testis antigens by autologous typing with T cell clones and the evolution of cancer vaccines. Cancer Immunity, 12:6-9.

Braun, S; Oppermann, H; Mueller, A; Renner, C; Hovhannisyan, A; Baran-Schmidt, R; Gebhardt, R; Hipkiss, A; Thiery, J; Meixensberger, J; Gaunitz, F (2012). Hedgehog signaling in glioblastoma multiforme. Cancer Biology & Therapy, 13(7):487-495.

Reiner, C S; Goetti, R; Burger, I A; Fischer, M A; Frauenfelder, T; Knuth, A; Pfammatter, T; Schaefer, N; Alkadhi, H (2012). Liver perfusion imaging in patients with primary and metastatic liver malignancy: prospective comparison between 99mTc-MAA spect and dynamic CT perfusion. Academic Radiology, 19(5):613-621.

Ummanni, R; Barreto, F; Venz, S; Scharf, C; Barett, C; Mannsperger, H A; Brase, J C; Kuner, R; Schlomm, T; Sauter, G; Sültmann, H; Korf, U; Bokemeyer, C; Walther, R; Brümmendorf, T H; Balabanov, S (2012). Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro. Journal of Proteome Research, 11(4):2452-2466.

Dyshlovoy, S A; Naeth, I; Venz, S; Preukschas, M; Sievert, H; Jacobsen, C; Shubina, L K; Gesell Salazar, M; Scharf, C; Walther, R; Krepstakies, M; Priyadarshini, P; Hauber, J; Fedorov, S N; Bokemeyer, C; Stonik, V A; Balabanov, S; Honecker, F (2012). Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity. Journal of Proteome Research, 11(4):2316-2330.

Noguchi, T; Kato, T; Wang, L; Maeda, Y; Ikeda, H; Sato, E; Knuth, A; Gnjatic, S; Ritter, G; Sakaguchi, S; Old, L J; Shiku, H; Nishikawa, H (2012). Intracellular tumor-associated antigens represent effective targets for passive immunotherapy. Cancer Research, 72(7):1672-1682.

Takizawa, H; Boettcher, S; Manz, M G (2012). Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood, 119(13):2991-3002.

Eiermann, W; Bergh, J; Cardoso, F; Conte, P; Crown, J; Curtin, N J; Gligorov, J; Gusterson, B; Joensuu, H; Linderholm, B K; Martin, M; Penault-Llorca, F; Pestalozzi, B C; Razis, E; Sotiriou, C; Tjulandin, S; Viale, G (2012). Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design. Breast, 21(1):20-26.

Mey, U; Hitz, F; Lohri, A; Pederiva, S; Taverna, C; Tzankov, A; Meier, O; Yeow, K; Renner, C (2012). Diagnosis and treatment of diffuse large B-cell lymphoma. Swiss Medical Weekly, 142:w13511.

Goetti, R; Reiner, C S; Knuth, A; Klotz, E; Stenner, F; Samaras, P; Alkadhi, H (2012). Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound. Investigative Radiology, 47(1):18-24.

Stenner, Frank; Chastonay, Rahel; Liewen, Heike; Haile, Sarah R; Cathomas, Richard; Rothermundt, Christian; Siciliano, Raffaele D; Stoll, Susanna; Knuth, Alexander; Buchler, Tomas; Porta, Camillo; Renner, Christoph; Samaras, Panagiotis (2012). A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma. Oncology, 82(6):333-340.

Scagliotti, Giorgio; Stahel, Rolf A; Rosell, Rafael; Thatcher, Nick; Soria, Jean-Charles (2012). ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development. European Journal of Cancer, 48(7):961-973.

Nitzsche, B; Gloesenkamp, C; Schrader, M; Hoffmann, B; Zengerling, F; Balabanov, S; Honecker, F; Höpfner, M (2012). Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer. British Journal of Cancer, 107(11):1853-1863.

Riklin, C; Seystahl, K; Hofer, S; Happold, C; Winterhalder, R; Weller, M (2012). Antiangiogenic treatment for multiple CNS hemangioblastomas. Onkologie, 35(7-8):443-445.

Gnannt, Ralph; Winklehner, Anna; Eberli, Daniel; Knuth, Alexander; Frauenfelder, Thomas; Alkadhi, Hatem (2012). Automated tube potential selection for standard chest and abdominal CT in follow-up patients with testicular cancer: comparison with fixed tube potential. European Radiology, 22(9):1937-1945.

Stahel, Rolf (2012). Biomarker testing in non-small cell lung cancer: to move forward with quality. Clinical and Translational Oncology, 14(5):321-322.

Lehmann, Kuno; Rickenbacher, Andreas; Weber, Achim; Pestalozzi, Bernhard C; Clavien, Pierre-Alain (2012). Chemotherapy before liver resection of colorectal metastases: friend or foe? Annals of Surgery, 255(2):237-247.

Schaefer, N G; Veit-Haibach, P; Soyka, J D; Steinert, H C; Stahel, R A (2012). Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): Value of 18F-FDG-PET/CT. European Journal of Radiology, 81(1):e19-e25.

Matter-Walstra, Klazien; Joerger, Markus; Kühnel, Ursula; Szucs, Thomas D; Pestalozzi, Bernhard; Schwenkglenks, Matthias (2012). Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the Swiss health care system. Value in Health, 15(1):65-71.

Scharl, M; Mwinyi, J; Fischbeck, A; Leucht, K; Eloranta, J J; Arikkat, J; Pesch, T; Kellermeier, S; Mair, A; Kullak-Ublick, G A; Truninger, K; Noreen, F; Regula, J; Gaj, P; Pittet, V; Mueller, C; Hofmann, C; Fried, M; McCole, D F; Rogler, G (2012). Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy. Inflammatory Bowel Diseases, 18(5):900-912.

Böttcher, Steffen. Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4-expressing nonhematopoietic cells. 2012, University of Zurich, Faculty of Medicine.

Misselwitz, B; Bachli, E B; Kaiser, P; Fehr, J; Goede, J S (2012). Diagnosis of hypersplenism with the epinephrine stimulation test - 23 years of experience at a tertiary care hospital. Swiss Medical Weekly, 2012(141):w13324.

Shi, Y; Felley-Bosco, E; Marti, T M; Stahel, R A (2012). Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy. PLoS ONE, 7(9):e45354.

Pavlidis, N; Stahel, R; Pentheroudakis, G; Cervantes, A (2012). ESMO Consensus Conferences: another source of ESMO Clinical Practice Guidelines. Annals of Oncology, 23(Supp 7):vii7-vii10.

Urner, Martin; Herrmann, Inge K; Buddeberg, Felix; Schuppli, Caroline; Roth Z'graggen, Birgit; Hasler, Melanie; Schanz, Urs; Mehr, Manuela; Spahn, Donat R; Beck Schimmer, Beatrice (2012). Effects of blood products on inflammatory response in endothelial cells in vitro. PLoS ONE, 7(3):e33403.